專業(yè)從事
生命科學儀器技術服務13382235337
ELICITYL總部位于法國格勒諾布爾，是一家致力于復雜糖類工程和生產的生物技術公司。該公司的任務是針對植物健康，藥學，營養(yǎng)保健品和化妝品為生物應用提供寡糖和多糖。
| 品牌 | 貨號 | 品名 | 規(guī)格 | 價格 |
| elicityl-oligotech | GLY090-NAc-sp3-Bt | 3'-Sialyllactose-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH-Biotin | 5mg | 詢價 |
| elicityl-oligotech | GLY092-NAc-sp3-Bt | GT3 Ganglioside oligosaccharide -NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH-Biotin | 5mg | 詢價 |
| elicityl-oligotech | GLY091-NAc-sp3-Bt | GD3 Ganglioside oligosaccharide -NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH-Biotin | 5mg | 詢價 |
| elicityl-oligotech | GLY093-NAc-sp3-Bt | GM2 Ganglioside oligosaccharide - Biotin | 5mg | 詢價 |
| elicityl-oligotech | GLY098-NAc-sp3-Bt | GD1a Ganglioside oligosaccharide - Biotin | 5mg | 詢價 |
| elicityl-oligotech | GLY096-NAc-sp3-Bt | GM1a Ganglioside oligosaccharide - Biotin | 5mg | 詢價 |
| elicityl-oligotech | ALG101 | Alginate polysaccharides (from Fucus vesiculosus) | 100mg | 374 |
| elicityl-oligotech | ALG102 | Alginate polysaccharides (from Ascophyllum nodosum) | 100mg | 374 |
| elicityl-oligotech | GLU312-99% | Maltose DP2 (>99% HPLC) | 100mg | 561 |
| elicityl-oligotech | ALG101 | Alginate polysaccharides (from Fucus vesiculosus) | 500mg | 654.5 |
| elicityl-oligotech | ALG103 | Alginate polysaccharides (from Chorda filum) | 100mg | 654.5 |
| elicityl-oligotech | ALG104 | Alginate polysaccharides (from Durvillaea antarctica) | 100mg | 654.5 |
| elicityl-oligotech | ALG100 | Alginate polysaccharides (from Laminaria japonica) | 100mg | 841.5 |
| elicityl-oligotech | ALG101 | Alginate polysaccharides (from Fucus vesiculosus) | 1000mg | 841.5 |
| elicityl-oligotech | ALG102 | Alginate polysaccharides (from Ascophyllum nodosum) | 1000mg | 841.5 |
| elicityl-oligotech | GLU200 | Xanthan gum polysaccharide | 100mg | 841.5 |
| elicityl-oligotech | GLU420 | Chitosan polysaccharide | 1000mg | 935 |
| elicityl-oligotech | ARB106 | Arabinan polysaccharides from sugar Beet | 100mg | 1122 |
| elicityl-oligotech | GLY142 | N-acetylmannosamine | 1000mg | 1122 |
| elicityl-oligotech | GLY143-99% | L-Fucose | 1000mg | 1122 |
| elicityl-oligotech | ALG103 | Alginate polysaccharides (from Chorda filum) | 1000mg | 1309 |
| elicityl-oligotech | ALG104 | Alginate polysaccharides (from Durvillaea antarctica) | 1000mg | 1309 |
| elicityl-oligotech | FRU110 | Fructo-oligosaccharides mixture from Jerusalem artichoke (Cut-off < 10kDa) | 100mg | 1309 |
| elicityl-oligotech | FUC400 | Fucoidan polysaccharide from Ascophyllum nodosum | 100mg | 1402.5 |
| elicityl-oligotech | FUC500 | Fucoidan polysaccharide from Durvillea antarctica | 100mg | 1402.5 |
| elicityl-oligotech | GLY070-70% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>70% NMR) | 5mg | 1402.5 |
| elicityl-oligotech | GLY141 | N-acetylgalactosamine | 1000mg | 1402.5 |
| elicityl-oligotech | GLY140-80% | Sialic acid (N-acetylneuraminic acid) (>80% NMR) | 1000mg | 1589.5 |
| elicityl-oligotech | GAL100 | Sulfated Arabinogalactan polysaccharide (from Codium f.) Native grade | 1000mg | 1683 |
| elicityl-oligotech | GLU314-95% | Maltotetraose DP4 (>95% HPLC) | 25mg | 1776.5 |
| elicityl-oligotech | GLU315-95% | Maltopentaose DP5 (>95% HPLC) | 25mg | 1776.5 |
| elicityl-oligotech | GLY060-90% | 3 Fucosyllactose / 3-FL (>90% NMR) | 5mg | 1776.5 |
| elicityl-oligotech | GLY140-90% | Sialic acid (N-acetylneuraminic acid) (>90% NMR) | 1000mg | 1776.5 |
| elicityl-oligotech | GLY090-90% | 3'-Sialyllactose / GM3 Ganglioside oligosaccharide (>90% NMR) (Sodium salt) | 100mg | 1963.5 |
| elicityl-oligotech | GLU314-98% | Maltotetraose DP4 (>98% HPLC) | 25mg | 1870 |
| elicityl-oligotech | GLU316-95% | Maltohexaose DP6 (>95% HPLC) | 50mg | 1870 |
| elicityl-oligotech | GLU700 | Scleroglucan polysaccharide | 5000mg | 1870 |
| elicityl-oligotech | ALG300 | Guluronate oligosaccharides average DP20 (sodium salt) | 10mg | 2057 |
| elicityl-oligotech | ALG500 | Mannuronate oligosaccharides Average DP20 (sodium salt) | 25mg | 2057 |
| elicityl-oligotech | GLU312-95% | Maltose DP2 (>95% HPLC) | 500mg | 1963.5 |
| elicityl-oligotech | GLU314-99% | Maltotetraose DP4 (>99% HPLC) | 25mg | 1963.5 |
| elicityl-oligotech | GLU316-98% | Maltohexaose DP6 (>98% HPLC) | 50mg | 1963.5 |
| elicityl-oligotech | GLU317-90% | Maltoheptaose DP7 (>90% HPLC) | 50mg | 1963.5 |
| elicityl-oligotech | GLU318-90% | Maltooctaose DP8 (>90% HPLC) | 25mg | 1963.5 |
| elicityl-oligotech | ALG600 | Manuronic Block OLS. DP30-DP50 M/G ratio>4 | 10mg | 2057 |
| elicityl-oligotech | ARB105 | Arabinan polysaccharides from Apple | 25mg | 2057 |
| elicityl-oligotech | FRU101-90% | 1-Kestose (DP3) / GF2 (>90% NMR) | 10mg | 2057 |
| elicityl-oligotech | FRU101-95% | 1-Kestose (DP3) / GF2 (>95% HPAEC-PAD) | 10mg | 2057 |
| elicityl-oligotech | FRU102-90% | Nystose (DP4) / GF3 (>90% NMR) | 10mg | 2057 |
| elicityl-oligotech | FRU102-95% | Nystose (DP4) / GF3 (>95% NMR) | 10mg | 2057 |
| elicityl-oligotech | FRU102-98% | Nystose (DP4) / GF3 (>98% HPAEC-PAD) | 10mg | 2057 |
| elicityl-oligotech | FRU111-90% | Fructo-oligosaccharide DP5 /GF4 / Fructofuranosyl-Nystose (>90% NMR) | 5mg | 2057 |
| elicityl-oligotech | FRU111-95% | Fructo-oligosaccharide DP5 /GF4 / Fructofuranosyl-Nystose (>95% HPAEC-PAD) | 5mg | 2057 |
| elicityl-oligotech | FRU112-70% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>70% HPAEC-PAD) | 5mg | 2057 |
| elicityl-oligotech | FRU114-70% | Fructo-oligosaccharide DP8 / GF7 (>70% HPAEC-PAD) | 5mg | 2057 |
| elicityl-oligotech | FUC310 | Fucoidan oligosaccharides (Cut-off < 10kDa) from Chorda filum | 10mg | 2057 |
| elicityl-oligotech | GAT114 | Galacturonan oligosaccharides Mixture DP10/DP15 | 10mg | 2057 |
| elicityl-oligotech | GAT300 | Rhamnogalacturonan polysaccharide from gombo/okra (sodium salt)) | 10mg | 2057 |
| elicityl-oligotech | GLU1111 | Reduced XFG xyloglucan oligosaccharide (DP7) XFGol | 10mg | 2057 |
| elicityl-oligotech | GLU1161 | Reduced XLFG xyloglucan oligosaccharide (DP10) XLFGol | 10mg | 2057 |
| elicityl-oligotech | GLU300-90% | Cellobiose (>90% HPAEC-PAD) | 10mg | 2057 |
| elicityl-oligotech | GLU301-90% | Cellotriose (>90% HPAEC-PAD) | 10mg | 2057 |
| elicityl-oligotech | GLU315-98% | Maltopentaose DP5 (>98% HPLC) | 25mg | 2057 |
| elicityl-oligotech | GLU316-90% | Maltohexaose DP6 (>90% HPLC) | 100mg | 2057 |
| elicityl-oligotech | GLU317-95% | Maltoheptaose DP7 (>95% HPLC) | 50mg | 2057 |
| elicityl-oligotech | GLU422 | Chitosan oligosaccharide - average DP60 | 10mg | 2057 |
| elicityl-oligotech | GLU423 | Chitosan oligosaccharide - average DP40 | 10mg | 2057 |
| elicityl-oligotech | GLU424 | Chitosan oligosaccharide - average DP24 | 10mg | 2057 |
| elicityl-oligotech | GLU425 | Chitosan oligosaccharide - average DP12 | 10mg | 2057 |
| elicityl-oligotech | GLU426 | Chitosan oligosaccharide - average DP6 | 10mg | 2057 |
| elicityl-oligotech | GLU427 | Chitosan oligosaccharide - average DP15-20 | 10mg | 2057 |
| elicityl-oligotech | GLU511 | Curdlan polysaccharide β-(1-3) linked linear glucan prepared by bacterial fermentation | 100mg | 2057 |
| elicityl-oligotech | GLU601 | Isolichenan polysaccharide | 100mg | 2057 |
| elicityl-oligotech | GLU602 | Lichenan & Isolichenan polysaccharide Native grade | 1000mg | 2057 |
| elicityl-oligotech | GLU800 | Lentinan polysaccharide | 10mg | 2057 |
| elicityl-oligotech | GLY008-80% | N-Acetyl-D-Lactosamine (LacNAc) (>80% NMR) | 5mg | 2057 |
| elicityl-oligotech | GLY008-90% | N-Acetyl-D-Lactosamine (LacNAc) (>90% NMR) | 5mg | 2057 |
| elicityl-oligotech | GLY021-90% | Lacto-N-neotetraose (LNnT / neo-LNT) | 5mg | 2057 |
| elicityl-oligotech | GLY030-80% | Blood group H antigen disaccharide (>80% NMR) | 5mg | 2057 |
| elicityl-oligotech | GLY030-90% | Blood group H antigen disaccharide (>90% NMR) | 5mg | 2057 |
| elicityl-oligotech | GLY031-2-50% | Blood group H antigen triaose type 2 (>50% NMR) | 5mg | 2057 |
| elicityl-oligotech | GLY031-2-95% | Blood group H antigen triaose type 2 (>95% NMR) | 5mg | 2057 |
| elicityl-oligotech | GLY060-95% | 3 Fucosyllactose (3-FL) (>95% NMR) | 5mg | 2057 |
| elicityl-oligotech | GLY153-90% | α1-3 galactobiose / Galα1-3Gal (>90% NMR) | 5mg | 2057 |
| elicityl-oligotech | GLY153-NPR | Galα1-3Gal-N-Acetyl-Propargyl | 1mg | 2057 |
| elicityl-oligotech | GLY221-AP | Galactose-β-Aminopropyl | 25mg | 2057 |
| elicityl-oligotech | MAN200 | Galactomannan polysaccharides from Guar | 500mg | 2057 |
| elicityl-oligotech | MAN201 | Galactomannan polysaccharides from Carob (locust bean gum) | 1000mg | 2057 |
| elicityl-oligotech | MAN202 | Galactomannan polysaccharide from Fenugreek | 100mg | 2057 |
| elicityl-oligotech | MAN600 | Glucomannan polysaccharide from Konjac | 1000mg | 2057 |
| elicityl-oligotech | MAN610 | Glucomannan oligosaccharides (cut-off < 10kDA) | 10mg | 2057 |
| elicityl-oligotech | ULV010 | Ulvan oligosaccharides (Cut-off < 10kDa) from Ulva sp. | 10mg | 2057 |
| elicityl-oligotech | ULV011 | Ulvan oligosaccharides (Cut-off < 10kDa) from Enteromorpha sp. | 10mg | 2057 |
| elicityl-oligotech | ULV100 | Ulvan polysaccharides from Ulva sp. Native grade | 100mg | 2057 |
| elicityl-oligotech | XYL110 | Xylan oligosaccharides XOs (Cut-off < 10kDA) from Palmaria p. | 10mg | 2057 |
| elicityl-oligotech | GLY089-85% | 2,6'-Sialyllactose (6'SL) (85% NMR) | 100mg | 2057 |
| elicityl-oligotech | GLY031-2-90% | Blood group H antigen triaose type 2 (>90% NMR) | 5mg | 2057 |
| elicityl-oligotech | ALG601 | Manuronic Block OLS. DP20-DP35 M/G ratio>4 | 10mg | 2150.5 |
| elicityl-oligotech | ALG610 | Guluronate Block OLS. DP25-DP45 | 10mg | 2150.5 |
| elicityl-oligotech | GAT110 | Galacturonan oligosaccharides blocks (OGAs) | 100mg | 2150.5 |
| elicityl-oligotech | GLU312-98% | Maltose DP2 (>98% HPLC) | 500mg | 2150.5 |
| elicityl-oligotech | GLU313-95% | Maltotriose DP3 (>95% HPLC) | 100mg | 2150.5 |
| elicityl-oligotech | GLU314-95% | Maltotetraose DP4 (>95% HPLC) | 50mg | 2150.5 |
| elicityl-oligotech | GLU315-99% | Maltopentaose DP5 (>99% HPLC) | 25mg | 2150.5 |
| elicityl-oligotech | GLU316-99% | Maltohexaose DP6 (>99% HPLC) | 50mg | 2150.5 |
| elicityl-oligotech | GLU318-90% | Maltooctaose DP8 (>90% HPLC) | 50mg | 2150.5 |
| elicityl-oligotech | GLU318-95% | Maltooctaose DP8 (>95% HPLC) | 25mg | 2150.5 |
| elicityl-oligotech | GLY031-3-85% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>85% NMR) | 5mg | 2150.5 |
| elicityl-oligotech | GLY090-95% | 3'-Sialyllactose / GM3 Ganglioside oligosaccharide (>95% NMR) (Sodium salt) | 100mg | 2337.5 |
| elicityl-oligotech | GAT200 | Apiogalacturonan polysaccharide (sodium salt) | 10mg | 2244 |
| elicityl-oligotech | GLU1141 | Reduced XLLG oligosaccharide (XLLGol) | 10mg | 2244 |
| elicityl-oligotech | GLU300-95% | Cellobiose (>95% HPAEC-PAD) | 10mg | 2244 |
| elicityl-oligotech | GLU301-95% | Cellotriose (>95% HPAEC-PAD) | 10mg | 2244 |
| elicityl-oligotech | GLU302-90% | Cellotetraose (>90% HPAEC-PAD) | 10mg | 2244 |
| elicityl-oligotech | GLU316-95% | Maltohexaose DP6 (>95% HPLC) | 100mg | 2244 |
| elicityl-oligotech | GLU411 | Colloidal Chitin polysaccharide | 100mg | 2244 |
| elicityl-oligotech | GLY009-90% | Lacto-N-Biose (>90% HPLC) | 5mg | 2244 |
| elicityl-oligotech | GLY010-90% | Lacto-N-tetraose (LNT) (>90% NMR) | 5mg | 2244 |
| elicityl-oligotech | GLY033-1-90% | Blood group H antigen pentaose type 1 / Lacto-N-fucopentaose I (LNFP I) (>90% NMR) | 5mg | 2244 |
| elicityl-oligotech | GLY070-90% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>90% NMR) | 5mg | 2244 |
| elicityl-oligotech | HGL200 | Glucurono-XyloMannan polysaccharide from Tremella fuciformis | 10mg | 2244 |
| elicityl-oligotech | GLY070-90% | copy of Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>90% NMR) | 5mg | 2244 |
| elicityl-oligotech | GLY070-90% | copy of Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>90% NMR) | 5mg | 2244 |
| elicityl-oligotech | FRU112-80% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>80% HPAEC-PAD) | 5mg | 2337.5 |
| elicityl-oligotech | GLU312-99% | Maltose DP2 (>99% HPLC) | 500mg | 2337.5 |
| elicityl-oligotech | GLU314-98% | Maltotetraose DP4 (>98% HPLC) | 50mg | 2337.5 |
| elicityl-oligotech | GLU315-95% | Maltopentaose DP5 (>95% HPLC) | 50mg | 2337.5 |
| elicityl-oligotech | GLU319-90% | Maltononaose DP9 (>90% HPLC) | 10mg | 2337.5 |
| elicityl-oligotech | GLU324-98% | Maltoundecaose DP11 (>98% HPLC) | 1mg | 2337.5 |
| elicityl-oligotech | GLY021-95% | Lacto-N-neotetraose (LNnT / neo-LNT) (>95% HPLC) | 5mg | 2337.5 |
| elicityl-oligotech | GLY089-95% | 2,6'-Sialyllactose (6'SL) (95% NMR) | 100mg | 2337.5 |
| elicityl-oligotech | ARB105 | Arabinan polysaccharides from Apple | 100mg | 2431 |
| elicityl-oligotech | GAT101 | Galacturonan polysaccharides HM from apple (sodium salt) | 1000mg | 2431 |
| elicityl-oligotech | GAT103 | Galacturonan polysaccharides HM from citrus (sodium salt) | 1000mg | 2431 |
| elicityl-oligotech | GLU301-98% | Cellotriose (>98% HPAEC-PAD) | 10mg | 2431 |
| elicityl-oligotech | GLU316-98% | Maltohexaose DP6 (>98% HPLC) | 100mg | 2431 |
| elicityl-oligotech | GLU326-98% | Maltododecaose DP12 (>98% HPLC) | 1mg | 2431 |
| elicityl-oligotech | GLU327-95% | Maltotridecaose DP13 (>95% HPLC) | 10mg | 2431 |
| elicityl-oligotech | GLU900 | Pustulan polysaccharide | 100mg | 2431 |
| elicityl-oligotech | GLY031-3-90% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>90% NMR) | 5mg | 2431 |
| elicityl-oligotech | GLU302-95% | Cellotetraose (>95% HPAEC-PAD) | 10mg | 2524.5 |
| elicityl-oligotech | GLY010-95% | Lacto-N-tetraose (LNT) (>95% HPLC) | 5mg | 2524.5 |
| elicityl-oligotech | GLY033-1-95% | Blood group H antigen pentaose type 1 / Lacto-N-fucopentaose I (LNFP I) (>95% NMR) | 5mg | 2524.5 |
| elicityl-oligotech | GLU313-98% | Maltotriose DP3 (>98% HPLC) | 100mg | 2618 |
| elicityl-oligotech | GLU314-99% | Maltotetraose DP4 (>99% HPLC) | 50mg | 2618 |
| elicityl-oligotech | GLU315-98% | Maltopentaose DP5 (>98% HPLC) | 50mg | 2618 |
| elicityl-oligotech | GLU318-98% | Maltooctaose DP8 (>98% HPLC) | 10mg | 2618 |
| elicityl-oligotech | GLU318-99% | Maltooctaose DP8 (>99% HPLC) | 10mg | 2618 |
| elicityl-oligotech | GLU320-90% | Maltodecaose DP10 (>90% HPLC) | 10mg | 2618 |
| elicityl-oligotech | GLU328-95% | Maltotetradecaose DP14 (>95% HPLC) | 10mg | 2618 |
| elicityl-oligotech | GLY070-95% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>95% NMR) | 5mg | 2618 |
| elicityl-oligotech | ALG310 | Guluronate oligosaccharides average DP10 (sodium salt) | 10mg | 2805 |
| elicityl-oligotech | ALG510 | Mannuronate oligosaccharides Average DP10 (sodium salt) | 10mg | 2805 |
| elicityl-oligotech | FRU101-90% | 1-Kestose (DP3) / GF2 (>90% NMR) | 25mg | 2711.5 |
| elicityl-oligotech | GAL110 | Sulfated Arabinogalactan oligosaccharides (cut-off < 10kDA) | 10mg | 2711.5 |
| elicityl-oligotech | GAT112 | Galacturonan oligosaccharides Mixture DP7/DP8 | 10mg | 2711.5 |
| elicityl-oligotech | GAT11x | Galacturonan oligosaccharides Mixture DP5/DP7 | 10mg | 2711.5 |
| elicityl-oligotech | GLU317-90% | Maltoheptaose DP7 (>90% HPLC) | 100mg | 2711.5 |
| elicityl-oligotech | GLU318-95% | Maltooctaose DP8 (>95% HPLC) | 50mg | 2711.5 |
| elicityl-oligotech | GLU432-90% | Chitin oligosaccharides DP2 /chitinbiose (>90% RMN) | 10mg | 2711.5 |
| elicityl-oligotech | GLU433-90% | Chitin oligosaccharides DP3 / chitintriose (>90% RMN) | 10mg | 2711.5 |
| elicityl-oligotech | GLU600 | Lichenan polysaccharide | 1000mg | 2711.5 |
| elicityl-oligotech | GLY120-90% | Globotriaose (Gb3) / Pk antigen (>90% HPLC) | 5mg | 2711.5 |
| elicityl-oligotech | MAN219 | Galactomannan oligosaccharides DP9 from Carob | 10mg | 2711.5 |
| elicityl-oligotech | MAN400 | α-galactosyl Mannobiose & Mannotriose | 10mg | 2711.5 |
| elicityl-oligotech | MAN802 | Mannan polysaccharide from Yeast | 10mg | 2711.5 |
| elicityl-oligotech | MAN810 | Mannan oligosaccharides (cut-off | 10mg | 2711.5 |
| elicityl-oligotech | FRU111-90% | Fructo-oligosaccharide DP5 /GF4 / Fructofuranosyl-Nystose (>90% NMR) | 10mg | 2805 |
| elicityl-oligotech | FUC300 | Fucoidan polysaccharide from Chorda filum | 100mg | 2805 |
| elicityl-oligotech | GLU315-95% | Maltopentaose DP5 (>95% HPLC) | 100mg | 2805 |
| elicityl-oligotech | GLU315-99% | Maltopentaose DP5 (>99% HPLC) | 50mg | 2805 |
| elicityl-oligotech | GLU316-99% | Maltohexaose DP6 (>99% HPLC) | 100mg | 2805 |
| elicityl-oligotech | GLU317-98% | Maltoheptaose DP7 (>98% HPLC) | 50mg | 2805 |
| elicityl-oligotech | GLU320-95% | Maltodecaose DP10 (>95% HPLC) | 10mg | 2805 |
| elicityl-oligotech | GLU328-98% | Maltotetradecaose DP14 (>98% HPLC) | 1mg | 2805 |
| elicityl-oligotech | GLY031-3-95% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>95% NMR) | 5mg | 2805 |
| elicityl-oligotech | GLY070-98% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>98% NMR) | 5mg | 2805 |
| elicityl-oligotech | GLY083-70% | LS-Tetrasaccharide d (LSTd) / Sialyl-lacto-N-neotetraose d (>70% NMR) (Sodium salt) | 1mg | 2805 |
| elicityl-oligotech | ALG300 | Guluronate oligosaccharides average DP20 (sodium salt) | 25mg | 3085.5 |
| elicityl-oligotech | FRU102-95% | Nystose (DP4) / GF3 (>95% NMR) | 25mg | 2898.5 |
| elicityl-oligotech | GLU302-98% | Cellotetraose (>98% HPAEC-PAD) | 10mg | 2898.5 |
| elicityl-oligotech | GLU511 | Curdlan polysaccharide β-(1-3) linked linear glucan prepared by bacterial fermentation | 1000mg | 2898.5 |
| elicityl-oligotech | GLY008-90% | N-Acetyl-D-Lactosamine (LacNAc) (>90% NMR) | 25mg | 2898.5 |
| elicityl-oligotech | GLY033-1-98% | Blood group H antigen pentaose type 1 / Lacto-N-fucopentaose I (LNFP I) (>98% NMR) | 5mg | 2898.5 |
| elicityl-oligotech | FRU102-98% | Nystose (DP4) / GF3 (>98% HPAEC-PAD) | 25mg | 2992 |
| elicityl-oligotech | FRU112-90% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>90% HPAEC-PAD) | 5mg | 2992 |
| elicityl-oligotech | GLU314-95% | Maltotetraose DP4 (>95% HPLC) | 100mg | 2992 |
| elicityl-oligotech | GLU318-90% | Maltooctaose DP8 (>90% HPLC) | 100mg | 2992 |
| elicityl-oligotech | GLU410 | Chitin polysaccharide | 1000mg | 2992 |
| elicityl-oligotech | GLU435-90% | Chitin oligosaccharides DP5 / chitinpentaose (>90% RMN) | 10mg | 2992 |
| elicityl-oligotech | GLY008-80% | N-Acetyl-D-Lactosamine (LacNAc) (>80% NMR) | 25mg | 2992 |
| elicityl-oligotech | GLY045-70% | Lewis b (Leb) tetraose (>70% NMR) | 5mg | 2992 |
| elicityl-oligotech | GLY048-70% | Lewis Y (LeY) tetraose (>70% NMR) | 5mg | 2992 |
| elicityl-oligotech | GLY120-95% | Globotriaose (Gb3) / Pk antigen (>95% HPLC) | 5mg | 2992 |
| elicityl-oligotech | MAN800 | Mannan polysaccharide (Ivory Nut or Tagua) - 1.4-beta-D-Mannan | 1000mg | 2992 |
| elicityl-oligotech | GLY089-85% | 2,6'-Sialyllactose (6'SL) (85% NMR) | 150mg | 2992 |
| elicityl-oligotech | GLY090-95% | 3'-Sialyllactose / GM3 Ganglioside oligosaccharide (>95% NMR) (Sodium salt) | 150mg | 3272.5 |
| elicityl-oligotech | ALG320 | Guluronate oligosaccharides average DP5 (sodium salt) | 10mg | 3272.5 |
| elicityl-oligotech | ALG520 | Mannuronate oligosaccharides Average DP5 (sodium salt) | 10mg | 3272.5 |
| elicityl-oligotech | FRU102-90% | Nystose (DP4) / GF3 (>90% NMR) | 25mg | 3085.5 |
| elicityl-oligotech | GLU313-99% | Maltotriose DP3 (>99% HPLC) | 100mg | 3085.5 |
| elicityl-oligotech | GLU317-95% | Maltoheptaose DP7 (>95% HPLC) | 100mg | 3085.5 |
| elicityl-oligotech | GLU317-99% | Maltoheptaose DP7 (>99% HPLC) | 50mg | 3085.5 |
| elicityl-oligotech | GLU319-90% | Maltononaose DP9 (>90% HPLC) | 25mg | 3085.5 |
| elicityl-oligotech | GLU700 | Scleroglucan polysaccharide | 10g | 3085.5 |
| elicityl-oligotech | GLY031-3-98% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>98% HPLC) | 5mg | 3085.5 |
| elicityl-oligotech | FRU101-95% | 1-Kestose (DP3) / GF2 (>95% HPAEC-PAD) | 25mg | 3179 |
| elicityl-oligotech | FRU111-95% | Fructo-oligosaccharide DP5 /GF4 / Fructofuranosyl-Nystose (>95% HPAEC-PAD) | 10mg | 3179 |
| elicityl-oligotech | FRU114-70% | Fructo-oligosaccharide DP8 / GF7 (>70% HPAEC-PAD) | 10mg | 3179 |
| elicityl-oligotech | GLU312-95% | Maltose DP2 (>95% HPLC) | 1000mg | 3179 |
| elicityl-oligotech | GLU313-95% | Maltotriose DP3 (>95% HPLC) | 500mg | 3179 |
| elicityl-oligotech | GLU314-98% | Maltotetraose DP4 (>98% HPLC) | 100mg | 3179 |
| elicityl-oligotech | GLU315-98% | Maltopentaose DP5 (>98% HPLC) | 100mg | 3179 |
| elicityl-oligotech | GLU320-99% | Maltodecaose DP10 (>99% HPLC) | 1mg | 3179 |
| elicityl-oligotech | GLU324-98% | Maltoundecaose DP11 (>98% HPLC) | 5mg | 3179 |
| elicityl-oligotech | GLY009-95% | Lacto-N-Biose (>95% HPLC) | 5mg | 3179 |
| elicityl-oligotech | GLY122-85% | Globopentaose (Gb5) / Stage Specific Embryonic Antigen 3a (SSEA-3a) (>85% NMR) | 5mg | 3179 |
| elicityl-oligotech | XYL100 | Xylan polysaccharide from Palmaria palmata | 1000mg | 3179 |
| elicityl-oligotech | GLY096-80% | GM1a Ganglioside oligosaccharide (>80%) (Sodium salt) | 5mg | 3459.5 |
| elicityl-oligotech | FRU117-60% | Fructo-oligosaccharide DP11 / GF10 (>60% HPAEC-PAD) | 10mg | 3272.5 |
| elicityl-oligotech | GAT100 | Galacturonate polysaccharides LM from apple (sodium salt) | 1000mg | 3272.5 |
| elicityl-oligotech | GAT111 | Galacturonan oligosaccharides Mixture DP3/DP4 | 10mg | 3272.5 |
| elicityl-oligotech | GLU303-90% | Cellopentaose (>90% HPAEC-PAD) | 10mg | 3272.5 |
| elicityl-oligotech | GLU327-95% | Maltotridecaose DP13 (>95% HPLC) | 25mg | 3272.5 |
| elicityl-oligotech | GLU421 | Chitosan oligosaccharides mixture | 100mg | 3272.5 |
| elicityl-oligotech | GLU434-90% | Chitin oligosaccharides DP4 / chitintetraose (>90% RMN) | 10mg | 3272.5 |
| elicityl-oligotech | GLY038-3-90% | Blood group B antigen tetraose type 5 (>90% NMR) | 5mg | 3272.5 |
| elicityl-oligotech | GLY055-90% | Lewis a (Le a) hexaose / Lacto-N-difucohexaose II (LNDFH II) (>90% NMR) | 5mg | 3272.5 |
| elicityl-oligotech | GLY083-90% | LS-Tetrasaccharide d (LSTd) / Sialyl-lacto-N-neotetraose d (>90% NMR) (Sodium salt) | 1mg | 3272.5 |
| elicityl-oligotech | GLY120-98% | Globotriaose (Gb3) / Pk antigen (>98% HPLC) | 5mg | 3272.5 |
| elicityl-oligotech | GLY121-90% | Globotetraose (Gb4) / P antigen (>90% NMR) | 5mg | 3272.5 |
| elicityl-oligotech | GLY154-90% | α1-4 galactobiose / Galα1-4Gal (>90% NMR) | 1mg | 3272.5 |
| elicityl-oligotech | GLY160 | Galactosyl-lactose | 5mg | 3272.5 |
| elicityl-oligotech | GLY161-90% | Difucosylpentaose | 5mg | 3272.5 |
| elicityl-oligotech | GLY162 | Disialosylpentaose | 5mg | 3272.5 |
| elicityl-oligotech | MAN213 | Galactomannan oligosaccharides DP3 from Carob | 10mg | 3272.5 |
| elicityl-oligotech | MAN215 | Galactomannan oligosaccharides DP5 from Carob | 10mg | 3272.5 |
| elicityl-oligotech | MAN300 | α-Digalactosyl mannopentaose | 10mg | 3272.5 |
| elicityl-oligotech | MAN801 | Acemannan polysaccharide (Aloe vera) | 10mg | 3272.5 |
| elicityl-oligotech | XYL101 | Glucurono-Arabinoxylan PLS from wheat bran | 100mg | 3272.5 |
| elicityl-oligotech | GLY089-95% | 2,6'-Sialyllactose (6'SL) (95% NMR) | 150mg | 3272.5 |
| elicityl-oligotech | GLU314-99% | Maltotetraose DP4 (>99% HPLC) | 100mg | 3366 |
| elicityl-oligotech | GLU320-90% | Maltodecaose DP10 (>90% HPLC) | 25mg | 3366 |
| elicityl-oligotech | GLU324-95% | Maltoundecaose DP11 (>95% HPLC) | 5mg | 3366 |
| elicityl-oligotech | GLU324-99% | Maltoundecaose DP11 (>99% HPLC) | 5mg | 3366 |
| elicityl-oligotech | GLU326-98% | Maltododecaose DP12 (>98% HPLC) | 5mg | 3366 |
| elicityl-oligotech | GLU328-95% | Maltotetradecaose DP14 (>95% HPLC) | 25mg | 3366 |
| elicityl-oligotech | GLY045-80% | Lewisb (Leb) tetraose (>80% NMR) | 5mg | 3366 |
| elicityl-oligotech | GLY180-50% | Glucuronyl-lactose / HNK 1 epitope precursor (Sodium salt) | 5mg | 3366 |
| elicityl-oligotech | FRU101-90% | 1-Kestose (DP3) / GF2 (>90% NMR) | 50mg | 3459.5 |
| elicityl-oligotech | FRU112-70% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>70% HPAEC-PAD) | 10mg | 3459.5 |
| elicityl-oligotech | GLU312-98% | Maltose DP2 (>98% HPLC) | 1000mg | 3459.5 |
| elicityl-oligotech | GLU313-98% | Maltotriose DP3 (>98% HPLC) | 500mg | 3459.5 |
| elicityl-oligotech | GLU317-98% | Maltoheptaose DP7 (>98% HPLC) | 100mg | 3459.5 |
| elicityl-oligotech | GLU319-90% | Maltononaose DP9 (>90% HPLC) | 50mg | 3459.5 |
| elicityl-oligotech | GLU319-95% | Maltononaose DP9 (>95% HPLC) | 5mg | 3459.5 |
| elicityl-oligotech | GLU420 | Chitosan polysaccharide | 10000mg | 3459.5 |
| elicityl-oligotech | GLY031-3-99% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>99% HPLC) | 5mg | 3459.5 |
| elicityl-oligotech | GLY081-85% | LS-Tetrasaccharide a (LSTa) / Sialyl-lacto-N-tetraose a (>85% NMR) (Sodium salt) | 5mg | 3459.5 |
| elicityl-oligotech | GLY221-AP | Galactose-β-Aminopropyl | 100mg | 3459.5 |
| elicityl-oligotech | ULV005 | Ulvan oligosaccharides (Cut-off: between 3 & 5kDa) from Enteromorpha sp. | 10mg | 3553 |
| elicityl-oligotech | ALG600 | Manuronic Block OLS. DP30-DP50 M/G ratio>4 | 25mg | 3646.5 |
| elicityl-oligotech | GLU315-99% | Maltopentaose DP5 (>99% HPLC) | 100mg | 3646.5 |
| elicityl-oligotech | GLU318-95% | Maltooctaose DP8 (>95% HPLC) | 100mg | 3646.5 |
| elicityl-oligotech | GLU326-95% | Maltododecaose DP12 (>95% HPLC) | 5mg | 3646.5 |
| elicityl-oligotech | GLU326-99% | Maltododecaose DP12 (>99% HPLC) | 5mg | 3646.5 |
| elicityl-oligotech | GLY021-90% | Lacto-N-neotetraose (LNnT / neo-LNT) | 10mg | 3646.5 |
| elicityl-oligotech | FRU102-90% | Nystose (DP4) / GF3 (>90% NMR) | 50mg | 3740 |
| elicityl-oligotech | GLU303-95% | Cellopentaose (>95% HPAEC-PAD) | 10mg | 3740 |
| elicityl-oligotech | GLU316-90% | Maltohexaose DP6 (>90% HPLC) | 250mg | 3740 |
| elicityl-oligotech | GLU318-90% | Maltooctaose DP8 (>90% HPLC) | 250mg | 3740 |
| elicityl-oligotech | GLU320-95% | Maltodecaose DP10 (>95% HPLC) | 25mg | 3740 |
| elicityl-oligotech | GLY143-99% | L-Fucose | 5000mg | 3740 |
| elicityl-oligotech | MAN200 | Galactomannan polysaccharides from Guar | 1000mg | 3740 |
| elicityl-oligotech | ALG530 | Mannuronate oligosaccharides DP3 (sodium salt) | 10mg | 4020.5 |
| elicityl-oligotech | GLU1000 | Xyloglucan oligosaccharides | 100mg | 3833.5 |
| elicityl-oligotech | GLU312-99% | Maltose DP2 (>99% HPLC) | 1000mg | 3833.5 |
| elicityl-oligotech | GLU313-99% | Maltotriose DP3 (>99% HPLC) | 500mg | 3833.5 |
| elicityl-oligotech | GLU316-95% | Maltohexaose DP6 (>95% HPLC) | 250mg | 3833.5 |
| elicityl-oligotech | GLU327-98% | Maltotridecaose DP13 (>98% HPLC) | 5mg | 3833.5 |
| elicityl-oligotech | GLU327-99% | Maltotridecaose DP13 (>99% HPLC) | 5mg | 3833.5 |
| elicityl-oligotech | GLU328-98% | Maltotetradecaose DP14 (>98% HPLC) | 5mg | 3833.5 |
| elicityl-oligotech | GLY008-80% | N-Acetyl-D-Lactosamine (LacNAc) (>80% NMR) | 100mg | 3833.5 |
| elicityl-oligotech | GLY060-95% | 3 Fucosyllactose (3-FL) (>95% NMR) | 10mg | 3833.5 |
| elicityl-oligotech | GLY132-90% | Forssman antigen pentaose | 1mg | 3833.5 |
| elicityl-oligotech | GLY097-80% | GM1b Ganglioside oligosaccharide (>80%) (Sodium salt) | 1mg | 4114 |
| elicityl-oligotech | GLY092-80% | GT3 Ganglioside oligosaccharide (>80%) (Sodium salt) | 1mg | 4114 |
| elicityl-oligotech | GLY096-90% | GM1a Ganglioside oligosaccharide (>90%) (Sodium salt) | 5mg | 4114 |
| elicityl-oligotech | ARB105 | Arabinan polysaccharides from Apple | 250mg | 3927 |
| elicityl-oligotech | FRU117-70% | Fructo-oligosaccharide DP11 / GF10 (>70% HPAEC-PAD) | 10mg | 3927 |
| elicityl-oligotech | GAT114 | Galacturonan oligosaccharides Mixture DP10/DP15 | 25mg | 3927 |
| elicityl-oligotech | GLY010-90% | Lacto-N-tetraose (LNT) (>90% NMR) | 10mg | 3927 |
| elicityl-oligotech | ALG330 | Guluronate oligosaccharides average DP3 (sodium salt) | 10mg | 4207.5 |
| elicityl-oligotech | GLU300-90% | Cellobiose (>90% HPAEC-PAD) | 100mg | 4020.5 |
| elicityl-oligotech | GLU319-90% | Maltononaose DP9 (>90% HPLC) | 100mg | 4020.5 |
| elicityl-oligotech | GLU319-98% | Maltononaose DP9 (>98% HPLC) | 5mg | 4020.5 |
| elicityl-oligotech | GLU319-99% | Maltononaose DP9 (>99% HPLC) | 5mg | 4020.5 |
| elicityl-oligotech | GLU320-90% | Maltodecaose DP10 (>90% HPLC) | 50mg | 4020.5 |
| elicityl-oligotech | GLU320-98% | Maltodecaose DP10 (>98% HPLC) | 5mg | 4020.5 |
| elicityl-oligotech | GLY153-NPR | Galα1-3Gal-N-Acetyl-Propargyl | 5mg | 4020.5 |
| elicityl-oligotech | FRU112-80% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>80% HPAEC-PAD) | 10mg | 4114 |
| elicityl-oligotech | FUC200 | Galactofucan polysaccharide from Undaria pinnatifida | 100mg | 4114 |
| elicityl-oligotech | GAL101 | Sulfated Arabinogalactan polysaccharide (from Codium f.) Fine grade | 100mg | 4114 |
| elicityl-oligotech | GAL111 | Sulfated Arabinogalactan oligosaccharides (Cut-off: between 3kDA & 10kDA) | 10mg | 4114 |
| elicityl-oligotech | GLU301-95% | Cellotriose (>95% HPAEC-PAD) | 50mg | 4114 |
| elicityl-oligotech | GLU304-80% | Cellohexaose (>80% HPAEC-PAD) | 10mg | 4114 |
| elicityl-oligotech | GLU317-99% | Maltoheptaose DP7 (>99% HPLC) | 100mg | 4114 |
| elicityl-oligotech | GLU436-90% | Chitin oligosaccharides DP6 / chitinhexaose (>90% RMN) | 10mg | 4114 |
| elicityl-oligotech | GLY021-95% | Lacto-N-neotetraose (LNnT / neo-LNT) (>95% HPLC) | 10mg | 4114 |
| elicityl-oligotech | GLY035-3-90% | Blood group A antigen tetraose type 5 (>90% NMR) | 5mg | 4114 |
| elicityl-oligotech | GLY046-75% | Lewis a (Lea) triaose | 5mg | 4114 |
| elicityl-oligotech | GLY048-90% | Lewis Y (LeY) tetraose (>90% NMR) | 5mg | 4114 |
| elicityl-oligotech | GLY049-90% | Lewis x (LeX) triaose /SSEA-1 / CD15 (>90% NMR) | 5mg | 4114 |
| elicityl-oligotech | GLY050-90% | Lewis x (LeX) tetraose (>90% NMR) | 5mg | 4114 |
| elicityl-oligotech | GLY052-90% | Lewis y (LeY) pentaose (>90% NMR) | 5mg | 4114 |
| elicityl-oligotech | GLY054-90% | Lewis a (Lea) tetraose (>90% NMR) | 5mg | 4114 |
| elicityl-oligotech | GLY056-90% | Lewis b (Le b) pentaose (>90% NMR) | 5mg | 4114 |
| elicityl-oligotech | GLY081-90% | LS-Tetrasaccharide a (LSTa) / Sialyl-lacto-N-tetraose a (>90% NMR) (Sodium salt) | 5mg | 4114 |
| elicityl-oligotech | GLY102-90% | aGM1 (asialo GM1) Ganglioside oligosaccharide / GA1 (>90% NMR) (Sodium salt) | 5mg | 4114 |
| elicityl-oligotech | GLY104-90% | aGM2 (asialo GM2) Ganglioside oligosaccharide / GA2 (>90% NMR) (Sodium salt) | 5mg | 4114 |
| elicityl-oligotech | GLY122-90% | Globopentaose (Gb5) / Stage Specific Embryonic Antigen 3a (SSEA-3a) (>90% NMR) | 5mg | 4114 |
| elicityl-oligotech | GLY125-90% | Globo-B heptaose (>90% NMR) | 1mg | 4114 |
| elicityl-oligotech | GLY221-NPR | Galactose-NAc-propargyl | 100mg | 4114 |
| elicityl-oligotech | ULV006 | Ulvan oligosaccharides (Cut-off: between 1 & 3kDa ) from Enteromorpha sp. | 10mg | 4114 |
| elicityl-oligotech | ULV100 | Ulvan polysaccharides from Ulva sp. Native grade | 1000mg | 4114 |
| elicityl-oligotech | ULV101 | Ulvan polysaccharides from Enteromorpha sp. Native grade | 1000mg | 4114 |
| elicityl-oligotech | XYL111 | Xylan oligosaccharides XOs (Cut-off: between 650Da & 3kDa) from Palmaria p. | 10mg | 4114 |
| elicityl-oligotech | GLY097-90% | GM1b Ganglioside oligosaccharide (>90%) (Sodium salt) | 1mg | 4488 |
| elicityl-oligotech | FRU118-70% | Fructo-oligosaccharide DP12 / GF11 (>70% HPAEC-PAD) | 10mg | 4207.5 |
| elicityl-oligotech | GLU1161 | Reduced XLFG xyloglucan oligosaccharide (DP10) XLFGol | 50mg | 4207.5 |
| elicityl-oligotech | GLU317-90% | Maltoheptaose DP7 (>90% HPLC) | 250mg | 4207.5 |
| elicityl-oligotech | GLU328-99% | Maltotetradecaose DP14 (>99% HPLC) | 5mg | 4207.5 |
| elicityl-oligotech | GLU329-95% | Maltopentadecaose DP15 (>95% HPLC) | 5mg | 4207.5 |
| elicityl-oligotech | GLY040-1-90% | Blood group B antigen hexaose type 1 (>90% NMR) | 1mg | 4207.5 |
| elicityl-oligotech | GLY151-95% | GalNAcβ1-3Gal / Gb4 Globoside terminal | 5mg | 4207.5 |
| elicityl-oligotech | GLY155 | GlcNAcβ1-3Gal | 5mg | 4207.5 |
| elicityl-oligotech | GLU328-90% | Maltotetradecaose DP14 (>90% HPLC) | 5mg | 4207.5 |
| elicityl-oligotech | GLU329-90% | Maltopentadecaose DP15 (>90% HPLC) | 5mg | 4207.5 |
| elicityl-oligotech | GLU329-85% | Maltopentadecaose DP15 (>85% HPLC) | 5mg | 4207.5 |
| elicityl-oligotech | FRU110 | Fructo-oligosaccharides mixture from Jerusalem artichoke (Cut-off < 10kDa) | 1000mg | 4301 |
| elicityl-oligotech | GLU303-98% | Cellopentaose (>98% HPAEC-PAD) | 10mg | 4301 |
| elicityl-oligotech | GLY073-90% | Isoglobopentaose / iGb5 | 1mg | 4301 |
| elicityl-oligotech | FRU102-95% | Nystose (DP4) / GF3 (>95% NMR) | 50mg | 4394.5 |
| elicityl-oligotech | GLU320-95% | Maltodecaose DP10 (>95% HPLC) | 50mg | 4394.5 |
| elicityl-oligotech | GLY033-2-90% | Blood group H antigen pentaose type 2 / Lacto-N-neofucopentaose I (LnNFP I) (>90% NMR) | 1mg | 4394.5 |
| elicityl-oligotech | GLU320-99% | Maltodecaose DP10 (>99% HPLC) | 5mg | 4488 |
| elicityl-oligotech | GLY011-90% | Lacto-N-Triaose (LNT2) (>90% NMR) | 5mg | 4488 |
| elicityl-oligotech | GLY030-80% | Blood group H antigen disaccharide (>80% NMR) | 25mg | 4488 |
| elicityl-oligotech | GLY032-1-70% | Blood group H antigen tetraose type 1 (>70% NMR) | 5mg | 4488 |
| elicityl-oligotech | GLY045-90% | Lewis b (Leb) tetraose (>90% NMR) | 5mg | 4488 |
| elicityl-oligotech | GLY062-80% | Lacto-N-fucopentaose V / LNFP V (>80% NMR) | 1mg | 4488 |
| elicityl-oligotech | GLY083-70% | LS-Tetrasaccharide d (LSTd) / Sialyl-lacto-N-neotetraose d (>70% NMR) (Sodium salt) | 5mg | 4488 |
| elicityl-oligotech | GLY111-80% | GM2 Ganglioside oligosaccharide analogue (>80% NMR) (Sodium salt) | 1mg | 4488 |
| elicityl-oligotech | GLY157-90% | 3 Sialylgalactose - GM4 (>90% NMR) | 1mg | 4488 |
| elicityl-oligotech | HGL101 | Sulfated heteropolysaccharides fine grade | 10mg | 4488 |
| elicityl-oligotech | GLU300-95% | Cellobiose (>95% HPAEC-PAD) | 100mg | 4581.5 |
| elicityl-oligotech | GLY010-95% | Lacto-N-tetraose (LNT) (>95% HPLC) | 10mg | 4581.5 |
| elicityl-oligotech | GLY090-95% | 3'-Sialyllactose / GM3 Ganglioside oligosaccharide (>95% NMR) (Sodium salt) | 250mg | 4955.5 |
| elicityl-oligotech | GLY099-80% | GD1b Ganglioside oligosaccharide (>80%) (Sodium salt) | 1mg | 4955.5 |
| elicityl-oligotech | GLY099-50% | GD1b Ganglioside oligosaccharide (>50%) (Sodium salt) | 1mg | 4955.5 |
| elicityl-oligotech | GLY096-95% | GM1a Ganglioside oligosaccharide (>95%) (Sodium salt) | 5mg | 4955.5 |
| elicityl-oligotech | FRU111-90% | Fructo-oligosaccharide DP5 /GF4 / Fructofuranosyl-Nystose (>90% NMR) | 25mg | 4675 |
| elicityl-oligotech | GLY080 | Sialylated tetraose type 1 (Sodium salt) | 1mg | 4675 |
| elicityl-oligotech | GLY129-85% | Blood group B antigen pentasaccharide type 4 (>85% NMR) | 5mg | 4675 |
| elicityl-oligotech | GLY089-85% | 2,6'-Sialyllactose (6'SL) (85% NMR) | 250mg | 4675 |
| elicityl-oligotech | GLU305-90% | Celloheptaose (>90% HPAEC-PAD) | 5mg | 4768.5 |
| elicityl-oligotech | GLU320-90% | Maltodecaose DP10 (>90% HPLC) | 100mg | 4768.5 |
| elicityl-oligotech | GLY035-3-95% | Blood group A antigen tetraose type 5 (>95% NMR) | 5mg | 4768.5 |
| elicityl-oligotech | GLY046-85% | Lewis a (Lea) triaose | 5mg | 4768.5 |
| elicityl-oligotech | ALG601 | Manuronic Block OLS. DP20-DP35 M/G ratio>4 | 25mg | 4862 |
| elicityl-oligotech | ALG610 | Guluronate Block OLS. DP25-DP45 | 25mg | 4862 |
| elicityl-oligotech | GLU316-98% | Maltohexaose DP6 (>98% HPLC) | 250mg | 4862 |
| elicityl-oligotech | GLY040-2-90% | Blood group B antigen hexaose type 2 (>90% NMR) | 1mg | 4862 |
| elicityl-oligotech | FRU101-95% | 1-Kestose (DP3) / GF2 (>95% HPAEC-PAD) | 50mg | 4955.5 |
| elicityl-oligotech | FRU114-70% | Fructo-oligosaccharide DP8 / GF7 (>70% HPAEC-PAD) | 25mg | 4955.5 |
| elicityl-oligotech | GLU304-90% | Cellohexaose (>90% HPAEC-PAD) | 10mg | 4955.5 |
| elicityl-oligotech | GLU310 | Maltodextrin High DP10-40 oligosaccharide mixture | 100mg | 4955.5 |
| elicityl-oligotech | GLU319-95% | Maltononaose DP9 (>95% HPLC) | 10mg | 4955.5 |
| elicityl-oligotech | GLY007-90% | Di-N-Acetyl-D-Lactosamine (>90% NMR) | 5mg | 4955.5 |
| elicityl-oligotech | GLY008-90% | N-Acetyl-D-Lactosamine (LacNAc) (>90% NMR) | 100mg | 4955.5 |
| elicityl-oligotech | GLY022-90% | Para-Lacto-N-neohexaose (Para-LNnH) (>90% NMR) | 1mg | 4955.5 |
| elicityl-oligotech | GLY023-90% | Lacto-N-neooctaose (LNnO) (>90%) | 1mg | 4955.5 |
| elicityl-oligotech | GLY047-90% | Sialyl LewisX (sLeX) tetraose (>90% NMR) | 5mg | 4955.5 |
| elicityl-oligotech | GLY074-2-90% | Xeno antigen type 2 / Galili antigen triaose / Galα -3 epitope/Linear B-2 trisaccharide (>90% NMR) | 5mg | 4955.5 |
| elicityl-oligotech | GLY126-90% | Core type 4 (Gb5 triaose core structure) | 5mg | 4955.5 |
| elicityl-oligotech | GLY154-90% | α1-4 galactobiose / Galα1-4Gal (>90% NMR) | 5mg | 4955.5 |
| elicityl-oligotech | GLY089-95% | 2,6'-Sialyllactose (6'SL) (95% NMR) | 250mg | 4955.5 |
| elicityl-oligotech | GLY047-80% | Sialyl LewisX (sLeX) tetraose (>80% NMR) | 5mg | 4955.5 |
| elicityl-oligotech | GLY031-2-50% | Blood group H antigen triaose type 2 (>50% NMR) | 25mg | 5049 |
| elicityl-oligotech | GLU313-95% | Maltotriose DP3 (>95% HPLC) | 1000mg | 5142.5 |
| elicityl-oligotech | GLU318-98% | Maltooctaose DP8 (>98% HPLC) | 25mg | 5142.5 |
| elicityl-oligotech | GLU318-99% | Maltooctaose DP8 (>99% HPLC) | 25mg | 5142.5 |
| elicityl-oligotech | GLU320-95% | Maltodecaose DP10 (>95% HPLC) | 100mg | 5142.5 |
| elicityl-oligotech | GLY011-95% | Lacto-N-Triaose (LNT2) (>95% HPLC) | 5mg | 5142.5 |
| elicityl-oligotech | GLY037-1-90% | Blood group A antigen hexaose type 1 (>90% NMR) | 1mg | 5142.5 |
| elicityl-oligotech | GLY037-2-90% | Blood group A antigen hexaose type 2 (>90% NMR) | 1mg | 5142.5 |
| elicityl-oligotech | FRU111-95% | Fructo-oligosaccharide DP5 /GF4 / Fructofuranosyl-Nystose (>95% HPAEC-PAD) | 25mg | 5236 |
| elicityl-oligotech | GLU316-99% | Maltohexaose DP6 (>99% HPLC) | 250mg | 5236 |
| elicityl-oligotech | GLY032-1-80% | Blood group H antigen tetraose type 1 (>80% NMR) | 5mg | 5236 |
| elicityl-oligotech | GLY142 | N-acetylmannosamine | 5000mg | 5236 |
| elicityl-oligotech | FRU102-98% | Nystose (DP4) / GF3 (>98% HPAEC-PAD) | 50mg | 5329.5 |
| elicityl-oligotech | FRU112-90% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>90% HPAEC-PAD) | 10mg | 5329.5 |
| elicityl-oligotech | FRU116-90% | Fructo-oligosaccharide DP10 / GF9 (>90% HPAEC-PAD) | 5mg | 5329.5 |
| elicityl-oligotech | GLU324-98% | Maltoundecaose DP11 (>98% HPLC) | 10mg | 5329.5 |
| elicityl-oligotech | GLY036-1-80% | Blood group A antigen pentaose type 1 (>80% NMR) | 1mg | 5329.5 |
| elicityl-oligotech | GLY072-90% | Isoglobotetraose / iGb4 / Cytolipin R (>90% NMR) | 1mg | 5329.5 |
| elicityl-oligotech | GLY111-90% | GM2 Ganglioside oligosaccharide analogue (>90% NMR) (Sodium salt) | 1mg | 5329.5 |
| elicityl-oligotech | GLY124-90% | Globo-A heptaose | 1mg | 5329.5 |
| elicityl-oligotech | GLY095-80% | GT2 Ganglioside oligosaccharide (>80%) (Sodium salt) | 1mg | 5797 |
| elicityl-oligotech | GLY100-80% | GT1a Ganglioside oligosaccharide (>80%) (Sodium salt) | 1mg | 5797 |
| elicityl-oligotech | GAL112 | Sulfated Arabinogalactan oligosaccharides (cut-off < 3kDa) | 10mg | 5516.5 |
| elicityl-oligotech | GLU305-95% | Celloheptaose (>95% HPAEC-PAD) | 5mg | 5516.5 |
| elicityl-oligotech | GLU313-98% | Maltotriose DP3 (>98% HPLC) | 1000mg | 5516.5 |
| elicityl-oligotech | GLU320-98% | Maltodecaose DP10 (>98% HPLC) | 10mg | 5516.5 |
| elicityl-oligotech | GLU323 | Cellodextrin Oligosaccharide mixture DP | 100mg | 5516.5 |
| elicityl-oligotech | ULV007 | Ulvan oligosaccharides (Cut-off: between 650Da & 1kDa) from Enteromorpha sp. | 10mg | 5516.5 |
| elicityl-oligotech | ALG100 | Alginate polysaccharides (from Laminaria japonica) | 1000mg | 5984 |
| elicityl-oligotech | ALG101 | Alginate polysaccharides (from Fucus vesiculosus) | 10000mg | 5984 |
| elicityl-oligotech | ALG102 | Alginate polysaccharides (from Ascophyllum nodosum) | 10000mg | 5984 |
| elicityl-oligotech | ALG310 | Guluronate oligosaccharides average DP10 (sodium salt) | 25mg | 6077.5 |
| elicityl-oligotech | ALG510 | Mannuronate oligosaccharides Average DP10 (sodium salt) | 25mg | 6077.5 |
| elicityl-oligotech | GLU200 | Xanthan gum polysaccharide | 1000mg | 5703.5 |
| elicityl-oligotech | GLU304-95% | Cellohexaose (>95% HPAEC-PAD) | 10mg | 5703.5 |
| elicityl-oligotech | GLU324-95% | Maltoundecaose DP11 (>95% HPLC) | 10mg | 5703.5 |
| elicityl-oligotech | GLU324-99% | Maltoundecaose DP11 (>99% HPLC) | 10mg | 5703.5 |
| elicityl-oligotech | GLU326-98% | Maltododecaose DP12 (>98% HPLC) | 10mg | 5703.5 |
| elicityl-oligotech | GLU327-95% | Maltotridecaose DP13 (>95% HPLC) | 50mg | 5703.5 |
| elicityl-oligotech | GLY060-90% | 3 Fucosyllactose / 3-FL (>90% NMR) | 25mg | 5703.5 |
| elicityl-oligotech | GLY066-90% | Lactodifucotetraose / Difucosyllactose / DF-L (>90% NMR) | 1mg | 5703.5 |
| elicityl-oligotech | GLY074-2-95% | Xeno antigen type 2 / Galili antigen triaose / Galα -3 epitope/Linear B-2 trisaccharide (>95% NMR) | 5mg | 5703.5 |
| elicityl-oligotech | GLY153-90% | α1-3 galactobiose / Galα1-3Gal (>90% NMR) | 25mg | 5703.5 |
| elicityl-oligotech | GLY157-90% | 3 Sialylgalactose - GM4 (>90% NMR) | 5mg | 5703.5 |
| elicityl-oligotech | GAT114 | Galacturonan oligosaccharides Mixture DP10/DP15 | 50mg | 5797 |
| elicityl-oligotech | GLU317-95% | Maltoheptaose DP7 (>95% HPLC) | 250mg | 5797 |
| elicityl-oligotech | GLY023-95% | Lacto-N-neooctaose (LNnO) (>95% HPLC) | 1mg | 5797 |
| elicityl-oligotech | GLY039-2-90% | Blood group B antigen pentaose type 2 (>90% NMR) | 1mg | 5797 |
| elicityl-oligotech | GLY051-75% | Lewis x (LeX) hexaose / Lacto-N-neodifucohexaose (LNnDFH) (>75% NMR) | 1mg | 5797 |
| elicityl-oligotech | GLY083-90% | LS-Tetrasaccharide d (LSTd) / Sialyl-lacto-N-neotetraose d (>90% NMR) (Sodium salt) | 5mg | 5797 |
| elicityl-oligotech | GLY101-80% | GT1c Ganglioside oligosaccharide (>80% NMR) (Sodium salt) | 1mg | 5797 |
| elicityl-oligotech | GLY051-90% | Lewis x (LeX) hexaose / Lacto-N-neodifucohexaose (LNnDFH) (>90% NMR) | 1mg | 5797 |
| elicityl-oligotech | GLY038-4-80% | Blood group B Lewisb antigen pentaose type 1 (>80% NMR) | 5mg | 5890.5 |
| elicityl-oligotech | GLY055-90% | Lewis a (Le a) hexaose / Lacto-N-difucohexaose II (LNDFH II) (>90% NMR) | 10mg | 5890.5 |
| elicityl-oligotech | GLY074-1-80% | Xeno antigen type 1 (>80% NMR) | 5mg | 5890.5 |
| elicityl-oligotech | GLY120-98% | Globotriaose (Gb3) / Pk antigen (>98% HPLC) | 10mg | 5890.5 |
| elicityl-oligotech | GLY251 | Galα1-4Galα1-4Galα1-4Galβ1-4Glc/ Galα1-4Galα1-4Gb3 | 1mg | 5890.5 |
| elicityl-oligotech | FUC100 | Fucoidan polysaccharide from Fucus vesiculosus | 100mg | 5984 |
| elicityl-oligotech | GLU422 | Chitosan oligosaccharide - average DP60 | 100mg | 5984 |
| elicityl-oligotech | GLU423 | Chitosan oligosaccharide - average DP40 | 100mg | 5984 |
| elicityl-oligotech | GLU424 | Chitosan oligosaccharide - average DP24 | 100mg | 5984 |
| elicityl-oligotech | GLY030-90% | Blood group H antigen disaccharide (>90% NMR) | 25mg | 5984 |
| elicityl-oligotech | GLY063 | 3’Sialyl-3Fucosyllactose / F-SL (Sodium salt) | 5mg | 5984 |
| elicityl-oligotech | GLY129-90% | Blood group B antigen pentasaccharide type 4 (>90% NMR) | 5mg | 5984 |
| elicityl-oligotech | GLY163-80% | 2'2 Difucosyllactose (>80% NMR) | 5mg | 5984 |
| elicityl-oligotech | GLY165-80% | Fucosylated B antigen type 5 (>80% NMR) | 5mg | 5984 |
| elicityl-oligotech | GLY092-90% | GT3 Ganglioside oligosaccharide (>90%) (Sodium salt) | 1mg | 6451.5 |
| elicityl-oligotech | GLY099-90% | GD1b Ganglioside oligosaccharide (>90%) (Sodium salt) | 1mg | 6451.5 |
| elicityl-oligotech | GLY094-90% | GD2 Ganglioside oligosaccharide (>90%) (Sodium salt) | 1mg | 6451.5 |
| elicityl-oligotech | GLY098-90% | GD1a Ganglioside oligosaccharide (>90%) (Sodium salt) | 1mg | 6451.5 |
| elicityl-oligotech | GLU313-99% | Maltotriose DP3 (>99% HPLC) | 1000mg | 6077.5 |
| elicityl-oligotech | GLU314-95% | Maltotetraose DP4 (>95% HPLC) | 250mg | 6077.5 |
| elicityl-oligotech | GLU316-90% | Maltohexaose DP6 (>90% HPLC) | 500mg | 6077.5 |
| elicityl-oligotech | GLU326-95% | Maltododecaose DP12 (>95% HPLC) | 10mg | 6077.5 |
| elicityl-oligotech | GLU326-99% | Maltododecaose DP12 (>99% HPLC) | 10mg | 6077.5 |
| elicityl-oligotech | GLU328-95% | Maltotetradecaose DP14 (>95% HPLC) | 50mg | 6077.5 |
| elicityl-oligotech | GLY061-90% | Lacto-N-neofucopentaose / LNnFP-V/LNFP VI | 1mg | 6077.5 |
| elicityl-oligotech | GLY082-85% | Sialylated tetraose type 2 (Sodium salt) (>85% NMR) | 1mg | 6077.5 |
| elicityl-oligotech | GLY136 | Globotriaose analogue type 2/ P1 antigen | 1mg | 6077.5 |
| elicityl-oligotech | GLY100-90% | GT1a Ganglioside oligosaccharide (>90%) (Sodium salt) | 1mg | 6545 |
| elicityl-oligotech | GLY095-90% | GT2 Ganglioside oligosaccharide (>90%) (Sodium salt) | 1mg | 6545 |
| elicityl-oligotech | FRU113-95% | Fructo-oligosaccharide DP7 / GF6 / 1-F-(1-β-fructofuranosyl)-3-nystose (>95% HPAEC-PAD) | 5mg | 6171 |
| elicityl-oligotech | FRU113-90% | Fructo-oligosaccharide DP7 / GF6 / 1-F-(1-β-fructofuranosyl)-3-nystose (>90% HPAEC-PAD) | 5mg | 6171 |
| elicityl-oligotech | ARB106 | Arabinan polysaccharides from sugar Beet | 1000mg | 6264.5 |
| elicityl-oligotech | FRU112-70% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>70% HPAEC-PAD) | 25mg | 6264.5 |
| elicityl-oligotech | FRU112-95% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>95% HPAEC-PAD) | 5mg | 6264.5 |
| elicityl-oligotech | GLU1110 | XFG xyloglucan oligosaccharide (DP7) | 10mg | 6264.5 |
| elicityl-oligotech | GLU1160 | XLFG xyloglucan oligosaccharide (DP10) | 10mg | 6264.5 |
| elicityl-oligotech | GLU314-98% | Maltotetraose DP4 (>98% HPLC) | 250mg | 6264.5 |
| elicityl-oligotech | GLU318-90% | Maltooctaose DP8 (>90% HPLC) | 500mg | 6264.5 |
| elicityl-oligotech | GLY007-2-85% | Tri-N-Acetyl-D-Lactosamine (>85% NMR) | 5mg | 6264.5 |
| elicityl-oligotech | GLY023-98% | Lacto-N-neooctaose (LNnO) (>98% HPLC) | 1mg | 6264.5 |
| elicityl-oligotech | GLY024-90% | Galacto-N-Neopentaose Di LAcNac Gal (>90% NMR) | 5mg | 6264.5 |
| elicityl-oligotech | GLY031-1-70% | Blood group H antigen triaose type 1 (>70% NMR) | 5mg | 6264.5 |
| elicityl-oligotech | GLY031-1-80% | Blood group H antigen triaose type 1 (>80% NMR) | 5mg | 6264.5 |
| elicityl-oligotech | GLY031-1-90% | Blood group H antigen triaose type 1 (>90% NMR) | 5mg | 6264.5 |
| elicityl-oligotech | GLY031-1-95% | Blood group H antigen triaose type 1 (>95% NMR) | 5mg | 6264.5 |
| elicityl-oligotech | GLY031-2-50% | Blood group H antigen triaose type 2 (>50% NMR) | 50mg | 6264.5 |
| elicityl-oligotech | GLY066-95% | Lactodifucotetraose / Difucosyllactose / DF-L (>95% NMR) | 1mg | 6264.5 |
| elicityl-oligotech | GLY172-85% | Disialylated pentaose type 1 | 1mg | 6264.5 |
| elicityl-oligotech | GLY092-80% | GT3 Ganglioside oligosaccharide (>80%) (Sodium salt) | 5mg | 6732 |
| elicityl-oligotech | GLU305-98% | Celloheptaose (>98% HPAEC-PAD) | 5mg | 6358 |
| elicityl-oligotech | GLY036-2-90% | Blood group A antigen pentaose type 2 (>90% NMR) | 1mg | 6358 |
| elicityl-oligotech | GLY039-1-90% | Blood group B antigen pentaose type 1 (>90% NMR) | 1mg | 6358 |
| elicityl-oligotech | GLY081-85% | LS-Tetrasaccharide a (LSTa) / Sialyl-lacto-N-tetraose a (>85% NMR) (Sodium salt) | 10mg | 6358 |
| elicityl-oligotech | GLY134-90% | Isoforssman antigen pentaose | 1mg | 6358 |
| elicityl-oligotech | GLY171-85% | Sialylated globotriose/ 3Sialyl-Gb3 | 1mg | 6358 |
| elicityl-oligotech | GLY036-1-85% | Blood group A antigen pentaose type 1 (>85% NMR) | 1mg | 6358 |
| elicityl-oligotech | ALG500 | Mannuronate oligosaccharides Average DP20 (sodium salt) | 100mg | 6825.5 |
| elicityl-oligotech | FRU114-90% | Fructo-oligosaccharide DP8 / GF7 (>90% HPAEC-PAD) | 5mg | 6451.5 |
| elicityl-oligotech | FRU118-90% | Fructo-oligosaccharide DP12 / GF11 (>90% HPAEC-PAD) | 10mg | 6451.5 |
| elicityl-oligotech | GLU315-95% | Maltopentaose DP5 (>95% HPLC) | 250mg | 6451.5 |
| elicityl-oligotech | GLU317-90% | Maltoheptaose DP7 (>90% HPLC) | 500mg | 6451.5 |
| elicityl-oligotech | GLY060-95% | 3 Fucosyllactose (3-FL) (>95% NMR) | 25mg | 6451.5 |
| elicityl-oligotech | GLY071-90% | Galili antigen pentaose (>90% NMR) | 1mg | 6451.5 |
| elicityl-oligotech | GLY078-85% | Galili antigen nonaose (>85% NMR) | 1mg | 6451.5 |
| elicityl-oligotech | GLY131-90% | SSEA-4 hexaose / Stage-Specific Embryonic Antigen-4 hexaose (>90% NMR) | 1mg | 6451.5 |
| elicityl-oligotech | GLY174-90% | GalGalNac-aGM1 (GalGalNAc asialo GM1) Ganglioside oligosaccharide analogue | 1mg | 6451.5 |
| elicityl-oligotech | FRU114-95% | Fructo-oligosaccharide DP8 / GF7 (>95% HPAEC-PAD) | 5mg | 6451.5 |
| elicityl-oligotech | ALG300 | Guluronate oligosaccharides average DP20 (sodium salt) | 100mg | 6919 |
| elicityl-oligotech | GAT122 | Galacturonan Oligosaccharide DP2 | 10mg | 6545 |
| elicityl-oligotech | GAT123 | Galacturonan Oligosaccharide DP3 | 10mg | 6545 |
| elicityl-oligotech | GAT124 | Galacturonan Oligosaccharide DP4 | 10mg | 6545 |
| elicityl-oligotech | GLU304-98% | Cellohexaose (>98% HPAEC-PAD) | 10mg | 6545 |
| elicityl-oligotech | GLY031-3-99% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>99% HPLC) | 10mg | 6545 |
| elicityl-oligotech | GLY040-1-90% | Blood group B antigen hexaose type 1 (>90% NMR) | 5mg | 6545 |
| elicityl-oligotech | GLY040-2-90% | Blood group B antigen hexaose type 2 (>90% NMR) | 5mg | 6545 |
| elicityl-oligotech | GLY101-90% | GT1c Ganglioside oligosaccharide (>90% NMR) (Sodium salt) | 1mg | 6545 |
| elicityl-oligotech | LEC101 | LecB (PA-IIL) from Pseudomonas aeruginosa - (Bacterial protein produced in E. coli) | 1mg | 6545 |
| elicityl-oligotech | LEC102 | LecA (PA-IL) from Pseudomonas aeruginosa - (Bacterial protein produced in E. coli) | 1mg | 6545 |
| elicityl-oligotech | ULV102 | Ulvan polysaccharides from Ulva sp. Fine grade | 100mg | 6545 |
| elicityl-oligotech | ULV103 | Ulvan polysaccharides from Enteromorpha sp. Fine grade | 100mg | 6545 |
| elicityl-oligotech | ALG320 | Guluronate oligosaccharides average DP5 (sodium salt) | 25mg | 7199.5 |
| elicityl-oligotech | ALG520 | Mannuronate oligosaccharides Average DP5 (sodium salt) | 25mg | 7199.5 |
| elicityl-oligotech | GLU1140 | XLLG oligosaccharide | 10mg | 6732 |
| elicityl-oligotech | GLU1161 | Reduced XLFG xyloglucan oligosaccharide (DP10) XLFGol | 100mg | 6732 |
| elicityl-oligotech | GLU314-99% | Maltotetraose DP4 (>99% HPLC) | 250mg | 6732 |
| elicityl-oligotech | GLU316-95% | Maltohexaose DP6 (>95% HPLC) | 500mg | 6732 |
| elicityl-oligotech | GLU311 | Maltodextrin oligosaccharide mixture | 100mg | 6825.5 |
| elicityl-oligotech | GLY022-90% | Para-Lacto-N-neohexaose (Para-LNnH) (>90% NMR) | 5mg | 6825.5 |
| elicityl-oligotech | GLY031-3-85% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>85% NMR) | 25mg | 6825.5 |
| elicityl-oligotech | GLY032-1-90% | Blood group H antigen tetraose type 1 (>90% NMR) | 5mg | 6825.5 |
| elicityl-oligotech | GLY034-90% | Blood group A antigen triaose | 5mg | 6825.5 |
| elicityl-oligotech | GLY036-1-90% | Blood group A antigen pentaose type 1 (>90% NMR) | 1mg | 6825.5 |
| elicityl-oligotech | GLY037-1-90% | Blood group A antigen hexaose type 1 (>90% NMR) | 5mg | 6825.5 |
| elicityl-oligotech | GLY037-2-90% | Blood group A antigen hexaose type 2 (>90% NMR) | 5mg | 6825.5 |
| elicityl-oligotech | GLY038-1-90% | Blood group B antigen tetraose type 1 (>90% NMR) | 5mg | 6825.5 |
| elicityl-oligotech | GLY038-2-90% | Blood group B antigen tetraose type 2 (>90% NMR) | 5mg | 6825.5 |
| elicityl-oligotech | GLY084-2-90% | Sialylated triaose type 2/ 3'-α-sialyl-Acetyl-Lactosamine/ sialyl Lex precursor (>90% NMR) (Sodium salt) | 5mg | 6825.5 |
| elicityl-oligotech | GLY123-90% | Globo-H hexaose / Stage Specific Embryonic Antigen 3b (SSEA-3b) (>90% NMR) | 5mg | 6825.5 |
| elicityl-oligotech | GLY128-90% | Blood group A antigen pentaose type 4 (>90% NMR) | 5mg | 6825.5 |
| elicityl-oligotech | GLY220-NPR | Lactose-β-NAc-propargyl | 25mg | 6825.5 |
| elicityl-oligotech | GLY250-80% | Galα1-4Galα1-4Galβ1-4Glc / Galα1-4Gb3 (> 80% NMR) | 5mg | 6825.5 |
| elicityl-oligotech | GLY094-95% | GD2 Ganglioside oligosaccharide (>95%) (Sodium salt) | 1mg | 7386.5 |
| elicityl-oligotech | ALG342 | Guluronate oligosaccharides DP2 (sodium salt) | 10mg | 7386.5 |
| elicityl-oligotech | ALG343 | Guluronate oligosaccharides DP3 (sodium salt) | 10mg | 7386.5 |
| elicityl-oligotech | ALG344 | Guluronate oligosaccharides DP4 (sodium salt) | 10mg | 7386.5 |
| elicityl-oligotech | GLU317-98% | Maltoheptaose DP7 (>98% HPLC) | 250mg | 6919 |
| elicityl-oligotech | GLU327-98% | Maltotridecaose DP13 (>98% HPLC) | 10mg | 6919 |
| elicityl-oligotech | GLU327-99% | Maltotridecaose DP13 (>99% HPLC) | 10mg | 6919 |
| elicityl-oligotech | GLU328-98% | Maltotetradecaose DP14 (>98% HPLC) | 10mg | 6919 |
| elicityl-oligotech | GLU411 | Colloidal Chitin polysaccharide | 1000mg | 6919 |
| elicityl-oligotech | GLY034-NAc-sp1-NH2 | Blood group A antigen triaose-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 1mg | 6919 |
| elicityl-oligotech | GLY034-NAc-sp2-NH2 | Blood group A antigen triaose-NAc-CH2-(1.4-Tz)-(CH2)2-EG7-NH2 | 1mg | 6919 |
| elicityl-oligotech | GLY034-APTFAc | Blood group A antigen triaose-β-O-aminopropyl trifluoroacetate | 1mg | 6919 |
| elicityl-oligotech | GLY070-90% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>90% NMR) | 25mg | 6919 |
| elicityl-oligotech | GLY077-90% | Galili antigen heptaose (>90% NMR) | 1mg | 6919 |
| elicityl-oligotech | GLY141 | N-acetylgalactosamine | 5000mg | 6919 |
| elicityl-oligotech | GLY038-5-70% | Blood group B LewisY antigen pentaose type 2 (>70% NMR) | 5mg | 6919 |
| elicityl-oligotech | GLY070-90% | copy of Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>90% NMR) | 25mg | 6919 |
| elicityl-oligotech | GLY070-90% | copy of Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>90% NMR) | 25mg | 6919 |
| elicityl-oligotech | GLU1150 | XXFG oligosaccharide | 10mg | 7012.5 |
| elicityl-oligotech | GLU427 | Chitosan oligosaccharide - average DP15-20 | 100mg | 7012.5 |
| elicityl-oligotech | GLY035-1-90% | Blood group A antigen tetraose type 1 (>90% NMR) | 5mg | 7012.5 |
| elicityl-oligotech | GLY195-2 | SSEA-4 hexaose analogue type 2 | 5mg | 7012.5 |
| elicityl-oligotech | GLY197 | Isoglobotetraose analogue / iGb4 analogue | 5mg | 7012.5 |
| elicityl-oligotech | ARB105 | Arabinan polysaccharides from Apple | 1000mg | 7106 |
| elicityl-oligotech | FRU115-90% | Fructo-oligosaccharide DP9 / GF8 (>90% HPAEC-PAD) | 5mg | 7106 |
| elicityl-oligotech | GLY064-60% | α-3Galactosyl-3Fucosyllactose (>60% NMR) | 5mg | 7106 |
| elicityl-oligotech | GLY078-90% | Galili antigen nonaose (>90% NMR) | 1mg | 7106 |
| elicityl-oligotech | FRU115-95% | Fructo-oligosaccharide DP9 / GF8 (>95% HPAEC-PAD) | 5mg | 7106 |
| elicityl-oligotech | GLY091-90% | GD3 Ganglioside oligosaccharide / Disialyl lactose/ DS-L (>90%) (Sodium salt) | 5mg | 7667 |
| elicityl-oligotech | GLY093-90% | GM2 Ganglioside oligosaccharide (>90%) (Sodium salt) | 5mg | 7667 |
| elicityl-oligotech | GLU315-98% | Maltopentaose DP5 (>98% HPLC) | 250mg | 7199.5 |
| elicityl-oligotech | GLU319-98% | Maltononaose DP9 (>98% HPLC) | 10mg | 7199.5 |
| elicityl-oligotech | GLU319-99% | Maltononaose DP9 (>99% HPLC) | 10mg | 7199.5 |
| elicityl-oligotech | GLY024-95% | Galacto-N-Neopentaose Di LAcNac Gal (>95% NMR) | 5mg | 7199.5 |
| elicityl-oligotech | GLY132-90% | Forssman antigen pentaose | 5mg | 7199.5 |
| elicityl-oligotech | GLY140-90% | Sialic acid (N-acetylneuraminic acid) (>90% NMR) | 5000mg | 7199.5 |
| elicityl-oligotech | LEC101-Bt | LecB (PA-IIL) from Pseudomonas aeruginosa linked to Biotin - (Bacterial protein produced in E. coli) | 1mg | 7199.5 |
| elicityl-oligotech | LEC102-Bt | LecA (PA-IL) from Pseudomonas aeruginosa linked to Biotin - (Bacterial protein produced in E. coli) | 1mg | 7199.5 |
| elicityl-oligotech | LEC202 | RSL from Ralstonia solanacearum - (Bacterial protein produced in E. coli) | 1mg | 7199.5 |
| elicityl-oligotech | LEC301 | BC2LA from Burkholderia cenocepacia - (Bacterial protein produced in E. coli) | 1mg | 7199.5 |
| elicityl-oligotech | GLU328-99% | Maltotetradecaose DP14 (>99% HPLC) | 10mg | 7293 |
| elicityl-oligotech | FRU116-95% | Fructo-oligosaccharide DP10 / GF9 (>95% HPAEC-PAD) | 5mg | 7293 |
| elicityl-oligotech | GLU328-90% | Maltotetradecaose DP14 (>90% HPLC) | 10mg | 7293 |
| elicityl-oligotech | FRU112-80% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>80% HPAEC-PAD) | 25mg | 7386.5 |
| elicityl-oligotech | GLY031-3-13C labelled | 2'FL labelled 13C | 5mg | 7386.5 |
| elicityl-oligotech | GLY052-90% | Lewis y (LeY) pentaose (>90% NMR) | 10mg | 7386.5 |
| elicityl-oligotech | GLY054-90% | Lewis a (Lea) tetraose (>90% NMR) | 10mg | 7386.5 |
| elicityl-oligotech | GLY071-95% | Galili antigen pentaose (>95% NMR) | 1mg | 7386.5 |
| elicityl-oligotech | GLY081-90% | LS-Tetrasaccharide a (LSTa) / Sialyl-lacto-N-tetraose a (>90% NMR) (Sodium salt) | 10mg | 7386.5 |
| elicityl-oligotech | GLY102-90% | aGM1 (asialo GM1) Ganglioside oligosaccharide / GA1 (>90% NMR) (Sodium salt) | 10mg | 7386.5 |
| elicityl-oligotech | GLY092-90% | GT3 Ganglioside oligosaccharide (>90%) (Sodium salt) | 5mg | 7947.5 |
| elicityl-oligotech | GLU329-95% | Maltopentadecaose DP15 (>95% HPLC) | 10mg | 7480 |
| elicityl-oligotech | GLY111-80% | GM2 Ganglioside oligosaccharide analogue (>80% NMR) (Sodium salt) | 5mg | 7480 |
| elicityl-oligotech | GLU329-90% | Maltopentadecaose DP15 (>90% HPLC) | 10mg | 7480 |
| elicityl-oligotech | GLU329-85% | Maltopentadecaose DP15 (>85% HPLC) | 10mg | 7480 |
| elicityl-oligotech | GLY038-4-85% | Blood group B Lewisb antigen pentaose type 1 (>85% NMR) | 5mg | 7480 |
| elicityl-oligotech | GLU318-95% | Maltooctaose DP8 (>95% HPLC) | 250mg | 7573.5 |
| elicityl-oligotech | GLY230-90% | 2’FucosylLactulose / 2’FLactulose | 5mg | 7573.5 |
| elicityl-oligotech | GLY097-80% | GM1b Ganglioside oligosaccharide (>80%) (Sodium salt) | 5mg | 8134.5 |
| elicityl-oligotech | GLY005-90% | Core type 1 triaose | 5mg | 7667 |
| elicityl-oligotech | GLY006-90% | Core type 2 triaose | 5mg | 7667 |
| elicityl-oligotech | GLY007-3-90% | Tetra-N-Acetyl-D-Lactosamine | 5mg | 7667 |
| elicityl-oligotech | GLY012-90% | Para-Lacto-N-hexaose (Para-LNH) | 5mg | 7667 |
| elicityl-oligotech | GLY033-2-90% | Blood group H antigen pentaose type 2 / Lacto-N-neofucopentaose I (LnNFP I) (>90% NMR) | 5mg | 7667 |
| elicityl-oligotech | GLY035-2-90% | Blood group A antigen tetraose type 2 | 5mg | 7667 |
| elicityl-oligotech | GLY035-4-90% | Blood group A Lewisb antigen pentaose type 1 | 5mg | 7667 |
| elicityl-oligotech | GLY035-5-85% | Blood group A LewisY antigen pentaose type 2 | 5mg | 7667 |
| elicityl-oligotech | GLY067-70% | 3-Fucosylated Blood group A tetraose | 5mg | 7667 |
| elicityl-oligotech | GLY068 | 3-Fucosylated Blood group B tetraose | 5mg | 7667 |
| elicityl-oligotech | GLY074-1-85% | Xeno antigen type 1 (>85% NMR) | 5mg | 7667 |
| elicityl-oligotech | GLY075-90% | Xeno lewisX / α-Gal-LewisX | 5mg | 7667 |
| elicityl-oligotech | GLY103-90% | Fucosyl GM1 Ganglioside oligosaccharide (>90% NMR) (Sodium salt) | 5mg | 7667 |
| elicityl-oligotech | GLY127-90% | Blood group H antigen tetraose type 4 / Globo H tetraose -NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 5mg | 7667 |
| elicityl-oligotech | GLY130-85% | SSEA-4 tetraose / Stage-Specific Embryonic Antigen-4 tetraose | 5mg | 7667 |
| elicityl-oligotech | GLY133-90% | Forssman antigen triaose | 5mg | 7667 |
| elicityl-oligotech | GLY164 | Fucosylated A antigen type 5 | 5mg | 7667 |
| elicityl-oligotech | GLY165-90% | Fucosylated B antigen type 5 (>90% NMR) | 5mg | 7667 |
| elicityl-oligotech | GLY181-90% | Glucuronyl-LNT / Glucuronyl-Lacto-N-tetraose (>90% NMR) (Sodium salt) | 5mg | 7667 |
| elicityl-oligotech | GLY190 | Globotetraose analogue / Gb4 analogue | 5mg | 7667 |
| elicityl-oligotech | GLY191-1-90% | Globopentaose analogue type 1 / Gb5 analogue type 1 | 5mg | 7667 |
| elicityl-oligotech | GLY191-2-90% | Globopentaose analogue type 2 / Gb5 analogue type 2 | 5mg | 7667 |
| elicityl-oligotech | GLY194-1 | Globo-H analogue type 1 | 5mg | 7667 |
| elicityl-oligotech | GLY194-2-90% | Globo-H analogue type 2 | 5mg | 7667 |
| elicityl-oligotech | GLY195-1 | SSEA-4 hexaose analogue type 1 | 5mg | 7667 |
| elicityl-oligotech | GLY196-1-75% | Sialylated-SSEA-4 hexaose analogue type 1 | 5mg | 7667 |
| elicityl-oligotech | GLY198-1 | Isoglobopentaose analogue type 1 / iGb5 analogue type 1 | 5mg | 7667 |
| elicityl-oligotech | GLY201-1 | Isoglobo-H analogue type 1 | 5mg | 7667 |
| elicityl-oligotech | GLY201-2 | Isoglobo-H analogue type 2 | 5mg | 7667 |
| elicityl-oligotech | GLY202-1 | Sialylated isoglobopentaose analogue type 1 / Sialylated iGb5 analogue type 1 | 5mg | 7667 |
| elicityl-oligotech | GLY202-2 | Sialylated isoglobopentaose analogue type 2 / Sialylated iGb5 analogue type 2 | 5mg | 7667 |
| elicityl-oligotech | GLU318-98% | Maltooctaose DP8 (>98% HPLC) | 50mg | 7760.5 |
| elicityl-oligotech | GLU318-99% | Maltooctaose DP8 (>99% HPLC) | 50mg | 7760.5 |
| elicityl-oligotech | GLY031-3-90% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>90% NMR) | 25mg | 7760.5 |
| elicityl-oligotech | GLY038-4-90% | Blood group B Lewisb antigen pentaose type 1 (>90% NMR) | 5mg | 7760.5 |
| elicityl-oligotech | GLY038-5-90% | Blood group B LewisY antigen pentaose type 2 | 5mg | 7760.5 |
| elicityl-oligotech | GLY072-90% | Isoglobotetraose / iGb4 / Cytolipin R (>90% NMR) | 5mg | 7760.5 |
| elicityl-oligotech | GLY163-90% | 2'2 Difucosyllactose (>90% NMR) | 5mg | 7760.5 |
| elicityl-oligotech | GLU317-99% | Maltoheptaose DP7 (>99% HPLC) | 250mg | 7854 |
| elicityl-oligotech | GLU410 | Chitin polysaccharide | 10000mg | 7854 |
| elicityl-oligotech | GLY024-98% | Galacto-N-Neopentaose Di LAcNac Gal (>98% NMR) | 5mg | 7854 |
| elicityl-oligotech | GLY080 | Sialylated tetraose type 1 (Sodium salt) | 5mg | 7854 |
| elicityl-oligotech | LEC101-FITC | LecB (PA-IIL) from Pseudomonas aeruginosa linked to FITC - (Bacterial protein produced in E. coli) | 1mg | 7854 |
| elicityl-oligotech | LEC101-FITC | copy of LecA (PA-IL) from Pseudomonas aeruginosa linked to FITC - (Bacterial protein produced in E. coli) | 1mg | 7854 |
| elicityl-oligotech | LEC102-FITC | copy of LecB (PA-IIL) from Pseudomonas aeruginosa linked to FITC - (Bacterial protein produced in E. coli) | 1mg | 7854 |
| elicityl-oligotech | GLY090-95% | 3'-Sialyllactose / GM3 Ganglioside oligosaccharide (>95% NMR) (Sodium salt) | 500mg | 8415 |
| elicityl-oligotech | GLU315-99% | Maltopentaose DP5 (>99% HPLC) | 250mg | 7947.5 |
| elicityl-oligotech | GLU425 | Chitosan oligosaccharide - average DP12 | 100mg | 8041 |
| elicityl-oligotech | GLU426 | Chitosan oligosaccharide - average DP6 | 100mg | 8041 |
| elicityl-oligotech | GLY070-95% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>95% NMR) | 25mg | 8041 |
| elicityl-oligotech | GLY077-95% | Galili antigen heptaose (>95% NMR) | 1mg | 8041 |
| elicityl-oligotech | MAN201 | Galactomannan polysaccharides from Carob (locust bean gum) | 10000mg | 8041 |
| elicityl-oligotech | MAN202 | Galactomannan polysaccharide from Fenugreek | 1000mg | 8041 |
| elicityl-oligotech | GLY011-90% | Lacto-N-Triaose (LNT2) (>90% NMR) | 10mg | 8134.5 |
| elicityl-oligotech | GLY073-90% | Isoglobopentaose / iGb5 | 5mg | 8134.5 |
| elicityl-oligotech | GLY089-85% | 2,6'-Sialyllactose (6'SL) (85% NMR) | 500mg | 8134.5 |
| elicityl-oligotech | ALG542 | Manuronate oligosaccharide DP2 (sodium salt) | 10mg | 8228 |
| elicityl-oligotech | ALG543 | Manuronate oligosaccharide DP3 (sodium salt) | 10mg | 8228 |
| elicityl-oligotech | ALG544 | Manuronate oligosaccharide DP4 (sodium salt) | 10mg | 8228 |
| elicityl-oligotech | GAL100 | Sulfated Arabinogalactan polysaccharide (from Codium f.) Native grade | 5000mg | 8228 |
| elicityl-oligotech | GLU306-90% | Cellooctaose (>90% HPAEC-PAD) | 5mg | 8228 |
| elicityl-oligotech | GLU320-99% | Maltodecaose DP10 (>99% HPLC) | 10mg | 8228 |
| elicityl-oligotech | GLY032-2-90% | Blood group H antigen tetraose type 2 (>90% NMR) | 5mg | 8228 |
| elicityl-oligotech | GLY062-80% | Lacto-N-fucopentaose V / LNFP V (>80% NMR) | 5mg | 8228 |
| elicityl-oligotech | ALG530 | Mannuronate oligosaccharides DP3 (sodium salt) | 25mg | 8882.5 |
| elicityl-oligotech | FRU111-90% | Fructo-oligosaccharide DP5 /GF4 / Fructofuranosyl-Nystose (>90% NMR) | 50mg | 8321.5 |
| elicityl-oligotech | GLY021-90% | Lacto-N-neotetraose (LNnT / neo-LNT) | 25mg | 8321.5 |
| elicityl-oligotech | GLY079-90% | Galili antigen undecaose (>90% NMR) | 1mg | 8321.5 |
| elicityl-oligotech | GLU900 | Pustulan polysaccharide | 1000mg | 8415 |
| elicityl-oligotech | GLY089-95% | 2,6'-Sialyllactose (6'SL) (95% NMR) | 500mg | 8415 |
| elicityl-oligotech | ALG330 | Guluronate oligosaccharides average DP3 (sodium salt) | 25mg | 9163 |
| elicityl-oligotech | GLU1111 | Reduced XFG xyloglucan oligosaccharide (DP7) XFGol | 100mg | 8602 |
| elicityl-oligotech | GLU305-90% | Celloheptaose (>90% HPAEC-PAD) | 10mg | 8602 |
| elicityl-oligotech | GLY031-2-95% | Blood group H antigen triaose type 2 (>95% NMR) | 25mg | 8602 |
| elicityl-oligotech | GLY070-98% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>98% NMR) | 25mg | 8602 |
| elicityl-oligotech | GLY155 | GlcNAcβ1-3Gal | 25mg | 8602 |
| elicityl-oligotech | GLY031-2-90% | Blood group H antigen triaose type 2 (>90% NMR) | 25mg | 8602 |
| elicityl-oligotech | GLY097-90% | GM1b Ganglioside oligosaccharide (>90%) (Sodium salt) | 5mg | 9350 |
| elicityl-oligotech | GLY030-AP | Blood group H antigen disaccharide-O-aminopropyl | 1mg | 8789 |
| elicityl-oligotech | GLY126-AP | Core type 4 (Gb5 triaose core structure)-aminopropyl | 1mg | 8789 |
| elicityl-oligotech | GLY090-GEL | 3'-Sialyllactose grafted on gel matrix (3'SL-Gel) 1 ml | 1mg | 9443.5 |
| elicityl-oligotech | ALG600 | Manuronic Block OLS. DP30-DP50 M/G ratio>4 | 100mg | 8882.5 |
| elicityl-oligotech | FRU114-70% | Fructo-oligosaccharide DP8 / GF7 (>70% HPAEC-PAD) | 50mg | 8882.5 |
| elicityl-oligotech | GLY031-3-95% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>95% NMR) | 25mg | 8882.5 |
| elicityl-oligotech | GLY060-BSA | 3 Fucosyllactose linked to BSA | 1mg | 8882.5 |
| elicityl-oligotech | GLY090-AP | 3'-Sialyllactose-β-Aminopropyl / GM3 Ganglioside oligosaccharide-β-aminopropyl (Sodium salt) | 1mg | 9537 |
| elicityl-oligotech | GLU317-95% | Maltoheptaose DP7 (>95% HPLC) | 500mg | 8976 |
| elicityl-oligotech | GLU319-90% | Maltononaose DP9 (>90% HPLC) | 250mg | 8976 |
| elicityl-oligotech | GLY047-90% | Sialyl LewisX (sLeX) tetraose (>90% NMR) | 10mg | 8976 |
| elicityl-oligotech | GLY047-80% | Sialyl LewisX (sLeX) tetraose (>80% NMR) | 10mg | 8976 |
| elicityl-oligotech | GAT114 | Galacturonan oligosaccharides Mixture DP10/DP15 | 100mg | 9069.5 |
| elicityl-oligotech | GLY124-90% | Globo-A heptaose | 5mg | 9069.5 |
| elicityl-oligotech | GLU316-98% | Maltohexaose DP6 (>98% HPLC) | 500mg | 9163 |
| elicityl-oligotech | GLU436-90% | Chitin oligosaccharides DP6 / chitinhexaose (>90% RMN) | 25mg | 9163 |
| elicityl-oligotech | GLY009-90% | Lacto-N-Biose (>90% HPLC) | 25mg | 9163 |
| elicityl-oligotech | GLY010-90% | Lacto-N-tetraose (LNT) (>90% NMR) | 25mg | 9163 |
| elicityl-oligotech | GLY111-90% | GM2 Ganglioside oligosaccharide analogue (>90% NMR) (Sodium salt) | 5mg | 9256.5 |
| elicityl-oligotech | GLY125-90% | Globo-B heptaose (>90% NMR) | 5mg | 9256.5 |
| elicityl-oligotech | ALG103 | Alginate polysaccharides (from Chorda filum) | 10000mg | 10004.5 |
| elicityl-oligotech | ALG104 | Alginate polysaccharides (from Durvillaea antarctica) | 10000mg | 10004.5 |
| elicityl-oligotech | FRU111-95% | Fructo-oligosaccharide DP5 /GF4 / Fructofuranosyl-Nystose (>95% HPAEC-PAD) | 50mg | 9443.5 |
| elicityl-oligotech | GLU306-95% | Cellooctaose (>95% HPAEC-PAD) | 5mg | 9443.5 |
| elicityl-oligotech | FRU116-90% | Fructo-oligosaccharide DP10 / GF9 (>90% HPAEC-PAD) | 10mg | 9537 |
| elicityl-oligotech | GLY154-NPR | α1-4 galactobiose-NAc-propargyl | 1mg | 9537 |
| elicityl-oligotech | FRU112-90% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>90% HPAEC-PAD) | 25mg | 9630.5 |
| elicityl-oligotech | GLY006-NPR | Core type 2 triaose-β-N-acetyl-propargyl | 1mg | 9630.5 |
| elicityl-oligotech | GLY010-NPR | Lacto-N-tetraose-β-N-acetyl-propargyl | 1mg | 9630.5 |
| elicityl-oligotech | GLY021-95% | Lacto-N-neotetraose (LNnT / neo-LNT) (>95% HPLC) | 25mg | 9630.5 |
| elicityl-oligotech | GLY021-NPR | LNnT-β-N-acetyl-propargyl | 1mg | 9630.5 |
| elicityl-oligotech | GLY031-3-NPR | 2'FL-NAc-propargyl | 1mg | 9630.5 |
| elicityl-oligotech | GLY120-NPR | Globotriaose (Gb3)-NAc-propargyl | 1mg | 9630.5 |
| elicityl-oligotech | GLY122-NPR | Globopentaose (Gb5)-NAc-propargyl | 1mg | 9630.5 |
| elicityl-oligotech | GLY134-90% | Isoforssman antigen pentaose | 5mg | 9630.5 |
| elicityl-oligotech | GLY151-AP | GalNAcβ1-3Gal-aminopropyl | 5mg | 9630.5 |
| elicityl-oligotech | GLY250-NPR | Galα1-4Galα1-4Galβ1-4Glc-NAc-propargyl | 1mg | 9630.5 |
| elicityl-oligotech | GLY033-1-90% | Blood group H antigen pentaose type 1 / Lacto-N-fucopentaose I (LNFP I) (>90% NMR) | 25mg | 9724 |
| elicityl-oligotech | GLU303-95% | Cellopentaose (>95% HPAEC-PAD) | 50mg | 9817.5 |
| elicityl-oligotech | GLY031-3-98% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>98% HPLC) | 25mg | 9817.5 |
| elicityl-oligotech | GLU305-95% | Celloheptaose (>95% HPAEC-PAD) | 10mg | 9911 |
| elicityl-oligotech | GLU319-95% | Maltononaose DP9 (>95% HPLC) | 25mg | 9911 |
| elicityl-oligotech | GLY036-1-80% | Blood group A antigen pentaose type 1 (>80% NMR) | 5mg | 9911 |
| elicityl-oligotech | GLY100-80% | GT1a Ganglioside oligosaccharide (>80%) (Sodium salt) | 5mg | 10659 |
| elicityl-oligotech | FUC300 | Fucoidan polysaccharide from Chorda filum | 1000mg | 10004.5 |
| elicityl-oligotech | FUC310 | Fucoidan oligosaccharides (Cut-off < 10kDa) from Chorda filum | 100mg | 10004.5 |
| elicityl-oligotech | FUC400 | Fucoidan polysaccharide from Ascophyllum nodosum | 1000mg | 10004.5 |
| elicityl-oligotech | FUC500 | Fucoidan polysaccharide from Durvillea antarctica | 1000mg | 10004.5 |
| elicityl-oligotech | GLU301-90% | Cellotriose (>90% HPAEC-PAD) | 100mg | 10004.5 |
| elicityl-oligotech | GLU316-99% | Maltohexaose DP6 (>99% HPLC) | 500mg | 10004.5 |
| elicityl-oligotech | GLU320-90% | Maltodecaose DP10 (>90% HPLC) | 250mg | 10004.5 |
| elicityl-oligotech | GLU602 | Lichenan & Isolichenan polysaccharide Native grade | 10000mg | 10004.5 |
| elicityl-oligotech | GLU800 | Lentinan polysaccharide | 100mg | 10004.5 |
| elicityl-oligotech | MAN200 | Galactomannan polysaccharides from Guar | 10000mg | 10004.5 |
| elicityl-oligotech | MAN610 | Glucomannan oligosaccharides (cut-off < 10kDA) | 100mg | 10004.5 |
| elicityl-oligotech | ULV010 | Ulvan oligosaccharides (Cut-off < 10kDa) from Ulva sp. | 100mg | 10004.5 |
| elicityl-oligotech | ULV011 | Ulvan oligosaccharides (Cut-off < 10kDa) from Enteromorpha sp. | 100mg | 10004.5 |
| elicityl-oligotech | GLU324-98% | Maltoundecaose DP11 (>98% HPLC) | 25mg | 10098 |
| elicityl-oligotech | XYL110 | Xylan oligosaccharides XOs (Cut-off < 10kDA) from Palmaria p. | 100mg | 10098 |
| elicityl-oligotech | GLY091-GEL | GD3 Ganglioside oligosaccharide grafted on gel matrix - 1 ml | 1mg | 10846 |
| elicityl-oligotech | FRU113-95% | Fructo-oligosaccharide DP7 / GF6 / 1-F-(1-β-fructofuranosyl)-3-nystose (>95% HPAEC-PAD) | 10mg | 10191.5 |
| elicityl-oligotech | GLY031-1-BSA | Blood group H antigen triaose type 1 linked to BSA | 1mg | 10191.5 |
| elicityl-oligotech | GLY031-3-BSA | 2’Fucosyllactose linked to BSA | 1mg | 10191.5 |
| elicityl-oligotech | GLY033-1-BSA | Blood group H antigen pentaose type 1 linked to BSA | 1mg | 10191.5 |
| elicityl-oligotech | FRU113-90% | Fructo-oligosaccharide DP7 / GF6 / 1-F-(1-β-fructofuranosyl)-3-nystose (>90% HPAEC-PAD) | 10mg | 10191.5 |
| elicityl-oligotech | FUC600 | Fucoidan polysaccharide kit. 4 items each in 100 mg pack size | 100mg | 10285 |
| elicityl-oligotech | GAT102 | Galacturonate polysaccharides LM from citrus (sodium salt) | 1000mg | 10285 |
| elicityl-oligotech | REF060 | 3 Fucosyllactose (3-FL) Analytical Reference | 10mg | 10285 |
| elicityl-oligotech | REF089 | 2,6'-Sialyllactose (6'SL) (Sodium salt) Analytical Reference | 10mg | 10285 |
| elicityl-oligotech | GLY095-80% | GT2 Ganglioside oligosaccharide (>80%) (Sodium salt) | 5mg | 11033 |
| elicityl-oligotech | GLY074-2-95% | Xeno antigen type 2 / Galili antigen triaose / Galα -3 epitope/Linear B-2 trisaccharide (>95% NMR) | 10mg | 10378.5 |
| elicityl-oligotech | FRU112-95% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>95% HPAEC-PAD) | 10mg | 10472 |
| elicityl-oligotech | GLU327-95% | Maltotridecaose DP13 (>95% HPLC) | 100mg | 10472 |
| elicityl-oligotech | GLY031-3-99% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>99% HPLC) | 25mg | 10472 |
| elicityl-oligotech | GLY010-95% | Lacto-N-tetraose (LNT) (>95% HPLC) | 25mg | 10565.5 |
| elicityl-oligotech | GLY074-1-80% | Xeno antigen type 1 (>80% NMR) | 10mg | 10565.5 |
| elicityl-oligotech | GLU302-95% | Cellotetraose (>95% HPAEC-PAD) | 50mg | 10659 |
| elicityl-oligotech | GLU304-80% | Cellohexaose (>80% HPAEC-PAD) | 50mg | 10659 |
| elicityl-oligotech | GLY031-3-85% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>85% NMR) | 100mg | 10659 |
| elicityl-oligotech | GLY066-90% | Lactodifucotetraose / Difucosyllactose / DF-L (>90% NMR) | 5mg | 10659 |
| elicityl-oligotech | GLY101-80% | GT1c Ganglioside oligosaccharide (>80% NMR) (Sodium salt) | 5mg | 10659 |
| elicityl-oligotech | FRU114-90% | Fructo-oligosaccharide DP8 / GF7 (>90% HPAEC-PAD) | 10mg | 10846 |
| elicityl-oligotech | GLU306-98% | Cellooctaose (>98% HPAEC-PAD) | 5mg | 10846 |
| elicityl-oligotech | GLU320-95% | Maltodecaose DP10 (>95% HPLC) | 250mg | 10846 |
| elicityl-oligotech | GLU324-95% | Maltoundecaose DP11 (>95% HPLC) | 25mg | 10846 |
| elicityl-oligotech | GLU324-99% | Maltoundecaose DP11 (>99% HPLC) | 25mg | 10846 |
| elicityl-oligotech | GLU326-98% | Maltododecaose DP12 (>98% HPLC) | 25mg | 10846 |
| elicityl-oligotech | GLY039-2-90% | Blood group B antigen pentaose type 2 (>90% NMR) | 5mg | 10846 |
| elicityl-oligotech | GLY120-90% | Globotriaose (Gb3) / Pk antigen (>90% HPLC) | 25mg | 10846 |
| elicityl-oligotech | FRU114-95% | Fructo-oligosaccharide DP8 / GF7 (>95% HPAEC-PAD) | 10mg | 10846 |
| elicityl-oligotech | GAT110 | Galacturonan oligosaccharides blocks (OGAs) | 1000mg | 11033 |
| elicityl-oligotech | GLU320-98% | Maltodecaose DP10 (>98% HPLC) | 25mg | 11126.5 |
| elicityl-oligotech | GLY033-1-95% | Blood group H antigen pentaose type 1 / Lacto-N-fucopentaose I (LNFP I) (>95% NMR) | 25mg | 11126.5 |
| elicityl-oligotech | FRU112-70% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>70% HPAEC-PAD) | 50mg | 11220 |
| elicityl-oligotech | GLY051-75% | Lewis x (LeX) hexaose / Lacto-N-neodifucohexaose (LNnDFH) (>75% NMR) | 5mg | 11220 |
| elicityl-oligotech | GLY051-90% | Lewis x (LeX) hexaose / Lacto-N-neodifucohexaose (LNnDFH) (>90% NMR) | 5mg | 11220 |
| elicityl-oligotech | GLY022-90% | Para-Lacto-N-neohexaose (Para-LNnH) (>90% NMR) | 10mg | 11313.5 |
| elicityl-oligotech | MAN802 | Mannan polysaccharide from Yeast | 100mg | 11313.5 |
| elicityl-oligotech | REF090 | 3'-Sialyllactose (3'SL) (Sodium salt) Analytical Reference | 10mg | 11313.5 |
| elicityl-oligotech | GLU305-98% | Celloheptaose (>98% HPAEC-PAD) | 10mg | 11407 |
| elicityl-oligotech | GLU301-95% | Cellotriose (>95% HPAEC-PAD) | 100mg | 11500.5 |
| elicityl-oligotech | GLU326-95% | Maltododecaose DP12 (>95% HPLC) | 25mg | 11500.5 |
| elicityl-oligotech | GLU326-99% | Maltododecaose DP12 (>99% HPLC) | 25mg | 11500.5 |
| elicityl-oligotech | GLY251 | Galα1-4Galα1-4Galα1-4Galβ1-4Glc/ Galα1-4Galα1-4Gb3 | 5mg | 11594 |
| elicityl-oligotech | GLY090-90% | 3'-Sialyllactose / GM3 Ganglioside oligosaccharide (>90% NMR) (Sodium salt) | 1000mg | 12435.5 |
| elicityl-oligotech | GLY061-90% | Lacto-N-neofucopentaose / LNnFP-V/LNFP VI | 5mg | 11687.5 |
| elicityl-oligotech | GLU432-90% | Chitin oligosaccharides DP2 /chitinbiose (>90% RMN) | 50mg | 11781 |
| elicityl-oligotech | GLU433-90% | Chitin oligosaccharides DP3 / chitintriose (>90% RMN) | 50mg | 11781 |
| elicityl-oligotech | GLU314-95% | Maltotetraose DP4 (>95% HPLC) | 500mg | 11874.5 |
| elicityl-oligotech | GLY031-3-90% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>90% NMR) | 100mg | 11874.5 |
| elicityl-oligotech | GLU1000 | Xyloglucan oligosaccharides | 1000mg | 11968 |
| elicityl-oligotech | GLU328-95% | Maltotetradecaose DP14 (>95% HPLC) | 100mg | 11968 |
| elicityl-oligotech | GLU511 | Curdlan polysaccharide β-(1-3) linked linear glucan prepared by bacterial fermentation | 5000mg | 11968 |
| elicityl-oligotech | GLU601 | Isolichenan polysaccharide | 1000mg | 11968 |
| elicityl-oligotech | GLY120-95% | Globotriaose (Gb3) / Pk antigen (>95% HPLC) | 25mg | 11968 |
| elicityl-oligotech | GAT300 | Rhamnogalacturonan polysaccharide from gombo/okra (sodium salt)) | 100mg | 12061.5 |
| elicityl-oligotech | GLU314-98% | Maltotetraose DP4 (>98% HPLC) | 500mg | 12061.5 |
| elicityl-oligotech | GLY083-70% | LS-Tetrasaccharide d (LSTd) / Sialyl-lacto-N-neotetraose d (>70% NMR) (Sodium salt) | 25mg | 12061.5 |
| elicityl-oligotech | GLY036-1-85% | Blood group A antigen pentaose type 1 (>85% NMR) | 5mg | 12061.5 |
| elicityl-oligotech | GLY099-80% | GD1b Ganglioside oligosaccharide (>80%) (Sodium salt) | 5mg | 12903 |
| elicityl-oligotech | GLY099-90% | GD1b Ganglioside oligosaccharide (>90%) (Sodium salt) | 5mg | 12903 |
| elicityl-oligotech | GLY099-50% | GD1b Ganglioside oligosaccharide (>50%) (Sodium salt) | 5mg | 12903 |
| elicityl-oligotech | GLY100-90% | GT1a Ganglioside oligosaccharide (>90%) (Sodium salt) | 5mg | 12903 |
| elicityl-oligotech | GLY094-90% | GD2 Ganglioside oligosaccharide (>90%) (Sodium salt) | 5mg | 12903 |
| elicityl-oligotech | GLY098-90% | GD1a Ganglioside oligosaccharide (>90%) (Sodium salt) | 5mg | 12903 |
| elicityl-oligotech | FRU115-90% | Fructo-oligosaccharide DP9 / GF8 (>90% HPAEC-PAD) | 10mg | 12155 |
| elicityl-oligotech | FRU115-95% | Fructo-oligosaccharide DP9 / GF8 (>95% HPAEC-PAD) | 10mg | 12155 |
| elicityl-oligotech | GLY095-90% | GT2 Ganglioside oligosaccharide (>90%) (Sodium salt) | 5mg | 13090 |
| elicityl-oligotech | GLU314-99% | Maltotetraose DP4 (>99% HPLC) | 500mg | 12248.5 |
| elicityl-oligotech | GLU315-95% | Maltopentaose DP5 (>95% HPLC) | 500mg | 12248.5 |
| elicityl-oligotech | GLY077-90% | Galili antigen heptaose (>90% NMR) | 5mg | 12248.5 |
| elicityl-oligotech | GLY082-85% | Sialylated tetraose type 2 (Sodium salt) (>85% NMR) | 5mg | 12248.5 |
| elicityl-oligotech | LEC302 | BC2LC-Nt from Burkholderia cenocepacia - (Bacterial protein produced in E. coli) | 1mg | 12248.5 |
| elicityl-oligotech | FRU116-95% | Fructo-oligosaccharide DP10 / GF9 (>95% HPAEC-PAD) | 10mg | 12435.5 |
| elicityl-oligotech | GLU435-90% | Chitin oligosaccharides DP5 / chitinpentaose (>90% RMN) | 50mg | 12716 |
| elicityl-oligotech | GLY033-1-98% | Blood group H antigen pentaose type 1 / Lacto-N-fucopentaose I (LNFP I) (>98% NMR) | 25mg | 12716 |
| elicityl-oligotech | GLU317-98% | Maltoheptaose DP7 (>98% HPLC) | 500mg | 12903 |
| elicityl-oligotech | GLU318-95% | Maltooctaose DP8 (>95% HPLC) | 500mg | 12903 |
| elicityl-oligotech | GLU700 | Scleroglucan polysaccharide | 100g | 12903 |
| elicityl-oligotech | GLY009-95% | Lacto-N-Biose (>95% HPLC) | 25mg | 12903 |
| elicityl-oligotech | GLY023-90% | Lacto-N-neooctaose (LNnO) (>90%) | 5mg | 12903 |
| elicityl-oligotech | GLY035-3-90% | Blood group A antigen tetraose type 5 (>90% NMR) | 25mg | 12903 |
| elicityl-oligotech | GLY036-1-90% | Blood group A antigen pentaose type 1 (>90% NMR) | 5mg | 12903 |
| elicityl-oligotech | GLY036-2-90% | Blood group A antigen pentaose type 2 (>90% NMR) | 5mg | 12903 |
| elicityl-oligotech | GLY038-3-90% | Blood group B antigen tetraose type 5 (>90% NMR) | 25mg | 12903 |
| elicityl-oligotech | GLY066-95% | Lactodifucotetraose / Difucosyllactose / DF-L (>95% NMR) | 5mg | 12903 |
| elicityl-oligotech | GLY071-90% | Galili antigen pentaose (>90% NMR) | 5mg | 12903 |
| elicityl-oligotech | GLY084-2-90% | Sialylated triaose type 2/ 3'-α-sialyl-Acetyl-Lactosamine/ sialyl Lex precursor (>90% NMR) (Sodium salt) | 10mg | 12903 |
| elicityl-oligotech | GLY101-90% | GT1c Ganglioside oligosaccharide (>90% NMR) (Sodium salt) | 5mg | 12903 |
| elicityl-oligotech | GLY131-90% | SSEA-4 hexaose / Stage-Specific Embryonic Antigen-4 hexaose (>90% NMR) | 5mg | 12903 |
| elicityl-oligotech | GLY157-90% | 3 Sialylgalactose - GM4 (>90% NMR) | 25mg | 12903 |
| elicityl-oligotech | GLY160 | Galactosyl-lactose | 25mg | 12903 |
| elicityl-oligotech | GLY161-90% | Difucosylpentaose | 25mg | 12903 |
| elicityl-oligotech | GLY162 | Disialosylpentaose | 25mg | 12903 |
| elicityl-oligotech | GLY171-85% | Sialylated globotriose/ 3Sialyl-Gb3 | 5mg | 12903 |
| elicityl-oligotech | GLY039-1-90% | Blood group B antigen pentaose type 1 (>90% NMR) | 5mg | 12996.5 |
| elicityl-oligotech | GLY180-50% | Glucuronyl-lactose / HNK 1 epitope precursor (Sodium salt) | 25mg | 12996.5 |
| elicityl-oligotech | GLY120-98% | Globotriaose (Gb3) / Pk antigen (>98% HPLC) | 25mg | 13090 |
| elicityl-oligotech | GLY172-85% | Disialylated pentaose type 1 | 5mg | 13090 |
| elicityl-oligotech | MAN801 | Acemannan polysaccharide (Aloe vera) | 100mg | 13090 |
| elicityl-oligotech | GAL100 | Sulfated Arabinogalactan polysaccharide (from Codium f.) Native grade | 10000mg | 13183.5 |
| elicityl-oligotech | GLU327-98% | Maltotridecaose DP13 (>98% HPLC) | 25mg | 13183.5 |
| elicityl-oligotech | GLU327-99% | Maltotridecaose DP13 (>99% HPLC) | 25mg | 13183.5 |
| elicityl-oligotech | GLU328-98% | Maltotetradecaose DP14 (>98% HPLC) | 25mg | 13183.5 |
| elicityl-oligotech | GLY031-3-99% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>99% HPLC) | 50mg | 13183.5 |
| elicityl-oligotech | FRU112-80% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>80% HPAEC-PAD) | 50mg | 13277 |
| elicityl-oligotech | GLU301-98% | Cellotriose (>98% HPAEC-PAD) | 100mg | 13277 |
| elicityl-oligotech | GLY174-90% | GalGalNac-aGM1 (GalGalNAc asialo GM1) Ganglioside oligosaccharide analogue | 5mg | 13277 |
| elicityl-oligotech | ALG601 | Manuronic Block OLS. DP20-DP35 M/G ratio>4 | 100mg | 13370.5 |
| elicityl-oligotech | ALG610 | Guluronate Block OLS. DP25-DP45 | 100mg | 13370.5 |
| elicityl-oligotech | GLY122-85% | Globopentaose (Gb5) / Stage Specific Embryonic Antigen 3a (SSEA-3a) (>85% NMR) | 25mg | 13370.5 |
| elicityl-oligotech | REF021 | Lacto-N-neotetraose (LNnT / neo-LNT) Analytical Reference | 10mg | 13370.5 |
| elicityl-oligotech | GLY090-95% | 3'-Sialyllactose / GM3 Ganglioside oligosaccharide (>95% NMR) (Sodium salt) | 1000mg | 14305.5 |
| elicityl-oligotech | GLU309-95% | Cello-oligosaccharides Kit 10 mg DP2 to 5 (>95% HPAEC-PAD) and 10 mg DP6 (>80% HPAEC-PAD) | 10mg | 13464 |
| elicityl-oligotech | GLU318-98% | Maltooctaose DP8 (>98% HPLC) | 100mg | 13464 |
| elicityl-oligotech | GLU318-99% | Maltooctaose DP8 (>99% HPLC) | 100mg | 13464 |
| elicityl-oligotech | GLY230-90% | 2’FucosylLactulose / 2’FLactulose | 10mg | 13464 |
| elicityl-oligotech | GLY096-80% | GM1a Ganglioside oligosaccharide (>80%) (Sodium salt) | 25mg | 14586 |
| elicityl-oligotech | GLU315-98% | Maltopentaose DP5 (>98% HPLC) | 500mg | 13651 |
| elicityl-oligotech | GLY031-3-95% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>95% NMR) | 100mg | 13651 |
| elicityl-oligotech | GAT100 | Galacturonate polysaccharides LM from apple (sodium salt) | 5000mg | 13744.5 |
| elicityl-oligotech | GLY050-90% | Lewis x (LeX) tetraose (>90% NMR) | 25mg | 13744.5 |
| elicityl-oligotech | GLY055-90% | Lewis a (Le a) hexaose / Lacto-N-difucohexaose II (LNDFH II) (>90% NMR) | 25mg | 13744.5 |
| elicityl-oligotech | GLY121-90% | Globotetraose (Gb4) / P antigen (>90% NMR) | 25mg | 13744.5 |
| elicityl-oligotech | GLY089-85% | 2,6'-Sialyllactose (6'SL) (85% NMR) | 1000mg | 13744.5 |
| elicityl-oligotech | FRU117-85% | Fructo-oligosaccharide DP11 / GF10 (>85% HPAEC-PAD) | 10mg | 13931.5 |
| elicityl-oligotech | GLU434-90% | Chitin oligosaccharides DP4 / chitintetraose (>90% RMN) | 50mg | 14025 |
| elicityl-oligotech | GLY154-90% | α1-4 galactobiose / Galα1-4Gal (>90% NMR) | 25mg | 14025 |
| elicityl-oligotech | GLU328-99% | Maltotetradecaose DP14 (>99% HPLC) | 25mg | 14118.5 |
| elicityl-oligotech | GLU328-90% | Maltotetradecaose DP14 (>90% HPLC) | 25mg | 14118.5 |
| elicityl-oligotech | GLY094-95% | GD2 Ganglioside oligosaccharide (>95%) (Sodium salt) | 5mg | 15147 |
| elicityl-oligotech | GLU317-99% | Maltoheptaose DP7 (>99% HPLC) | 500mg | 14212 |
| elicityl-oligotech | GLY022-BSA | Para-Lacto-N-neohexaose linked to BSA | 1mg | 14212 |
| elicityl-oligotech | GLY030-80% | Blood group H antigen disaccharide (>80% NMR) | 100mg | 14212 |
| elicityl-oligotech | GLY030-90% | Blood group H antigen disaccharide (>90% NMR) | 100mg | 14212 |
| elicityl-oligotech | GLY122-BSA | Globopentaose (Gb5) linked to BSA | 1mg | 14212 |
| elicityl-oligotech | GLY123-BSA | Globo-H hexaose (SSEA-3b) linked to BSA | 1mg | 14212 |
| elicityl-oligotech | GLU315-99% | Maltopentaose DP5 (>99% HPLC) | 500mg | 14305.5 |
| elicityl-oligotech | GLU329-95% | Maltopentadecaose DP15 (>95% HPLC) | 25mg | 14305.5 |
| elicityl-oligotech | GLU420 | Chitosan polysaccharide | 100g | 14305.5 |
| elicityl-oligotech | GLU440-2 | Chitin-Oligosaccharides kit from DP 2 to DP 6 | 10mg | 14305.5 |
| elicityl-oligotech | GLY011-BSA | Lacto-N-Triaose (LNT2) linked on BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY021-BSA | Lacto-N-neotetraose linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY033-2-BSA | Blood group H antigen pentaose type 2 linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY035-3-BSA | Blood group A antigen tetraose type 5 linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY037-1-BSA | Blood group A antigen hexaose type 1 linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY037-2-BSA | Blood group A antigen hexaose type 2 linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY038-3-BSA | Blood group B antigen tetraose type 5 linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY040-1-BSA | Blood group B antigen hexaose type 1 linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY040-2-BSA | Blood group B antigen hexaose type 2 linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY055-BSA | Lewis a hexaose (LNDFH II) linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY064-BSA | α-3Galactosyl-3Fucosyllactose linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY067-BSA | 3-Fucosylated Blood group A tetraose linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY068-BSA | 3-Fucosylated Blood group B tetraose linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY070-90% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>90% NMR) | 100mg | 14305.5 |
| elicityl-oligotech | GLY070-BSA | Isoglobotriaose (IsoGb3) linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY072-BSA | Isoglobotetraose (Cytolipin R) linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY073-BSA | Isoglobopentaose (iGb5) linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY077-95% | Galili antigen heptaose (>95% NMR) | 5mg | 14305.5 |
| elicityl-oligotech | GLY078-85% | Galili antigen nonaose (>85% NMR) | 5mg | 14305.5 |
| elicityl-oligotech | GLY102-90% | aGM1 (asialo GM1) Ganglioside oligosaccharide / GA1 (>90% NMR) (Sodium salt) | 25mg | 14305.5 |
無錫藥科美生物科技有限公司專業(yè)從事生命科學行業(yè)前沿技術服務與產品進出口服務，歡迎訂購咨詢全球各國各種進口產品。
歡迎來到
聯(lián)系人：賴秀麗
地址：無錫市惠山區(qū)惠山大道1699號惠山生命科技園C區(qū)5棟5315室
郵箱：46606436@qq.com
傳真：